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Metal-free transformations of organotrifluoroborates are advantageous since they avoid 
using frequently expensive and sensitive transition metals. Lewis acid-catalyzed reactions 
involving organotrifluoroborates have emerged as an alternative to metal-catalyzed 
protocols. However, these methods rely on generating unstable boron dihalide species 
thereby resulting in low functional group tolerance.  
A Brønsted acid-catalyzed carbon-carbon bond forming methodology involving 
alkenyl- and alkynyltrifluoroborates and in situ generated carbocations has been 
developed. In the presence of HBF4, we have shown that organotrifluoroborates react with 
benzhydryl alcohols to afford alkenes and alkynes in good to excellent yields. This protocol 
features excellent atom economy since alcohols and organotrifluoroborates react in a 1:1 
ratio. Functional group tolerance superior to Lewis acid- and metal-catalyzed approaches 
was demonstrated. 
Furthermore, we were able to extend this method to 2-ethoxytetrahydrofuran which 
underwent direct substitution to afford functionalized furans in moderate to excellent 
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 1. INTRODUCTION 
 
1.1 POTASSIUM TRIFLUOROBORATE SALTS 
 
1.1.1 ORGANOBORON COMPOUNDS 
 
  In recent years, organoboron compounds have been increasingly used as reagents 
for carbon-carbon bond formation. Namely, this is due to the fact that these reagents have 
a low toxicity. In addition, these reagents are compatible with a wide range of functional 
groups[1]. The relative non-toxic nature of organoboron-containing compounds can be 
further supported by their presence in prescription pharmaceuticals (Figure 1). Bortezomib 
was initially approved by the FDA in 2003 for the treatment of multiple myeloma and 
mantle cell lymphoma. More recently, tavaborole was approved by the FDA in 2014 for 
the treatment of onychomycosis, a fungal infection of toenails. Additionally, earlier this 
year, the FDA accepted Anacor Pharmaceutical’s New Drug Application (NDA) for the 
approval of crisaborole for the potential treatment of atopic dermatitis. Results from the 
FDA with regards to this review are anticipated early next year. 
 
Figure 1: Organoboron-containing pharmaceuticals 
Boronic acids and boronate esters are two popular subclasses of organoboron 
compounds (Figure 2). However, their prolonged storage is not without issues. Boronic 




difficulties in stoichiometry determination[2]. When the hydroxyl groups of boronic acids 
are replaced by alkoxy or aryloxy groups, this results in the formation of boronate esters. 
This is advantageous since with the hydroxyl groups removed, boronate esters lose the 
capability of acting as hydrogen bond donors and are, therefore, less polar and easier to 
handle[3].  However, although they display a higher stability as compared to free boronic 
acids, they are generally less reactive[2]. Furthermore, both boronic acids and boronate 
esters are sensitive to air and moisture due to the presence of an empty p-orbital on the 
boron atom[1]. 
 
Figure 2: Organoboron compounds 
 In contrast, organotrifluoroborate salts have been gaining popularity as they have 
been shown to overcome the limitation of stability. Present as crystalline solids, they are 
both air and moisture stable, since they are not hygroscopic, which allows for indefinite 
storage at room temperature[2]. Organotrifluoroborates also exhibit greater intrinsic 
nucleophilicity than their boronic acid and boronate ester counterparts due to their 
tetracoordinated nature[4]. Furthermore, a wide variety are commercially available or can 
be easily prepared on a gram scale from inexpensive materials[1,2,5,6]. 
  Potassium hydrogen difluoride, KHF2, has been shown to serve as an appropriate 
fluorinating agent towards the synthesis of organotrifluoroborates and is compatible with 
many functional groups[2]. Over the years, several one-pot methods have been developed 
for the synthesis of trifluoroborate salts and several procedures are being continuously 
reported. Three general methods that use the inexpensive KHF2 reagent are shown below 
and are widely used today[6] (Scheme 1). Firstly, organotrifluoroborates can be prepared 
from organolithium or Grignard reagents through reaction with trialkylborates and then 
subsequent reaction with KHF2 (Scheme 1, Method A). Alternatively, hydroboration of 




alkanyl- or alkenyltrifluoroborates (Scheme 1, Method B). Lastly, treatment of boronic 
acids with aqueous KHF2 is another popular method to furnish organotrifluoroborates 
(Scheme 1, Method C). 
 
Scheme 1: General methods for the preparation of organotrifluoroborates 
  
 Although KHF2 is safe to handle, the HF2 ̄ anion can cause extensive etching of 
glassware. As a result, Guy Lloyd-Jones and coworkers recently reported a new method 
for organotrifluoroborate preparation (Scheme 2). Through the use of KF and L-(+)-tartaric 
acid, a variety of aromatic, vinylic, allylic and alkyl boronic acids were converted to the 
corresponding organotrifluoroborate[7]. Filtration of the product mixture to remove residual 
KF and potassium bitartrate byproduct, followed by evaporation resulted in directly 
obtaining the organotrifluoroborate product. The methodology was also applied to pinacol 
boronates.  
 




1.1.2 METAL-FREE REACTIONS OF TRIFLUOROBORATES 
 
  Organotrifluoroborates have been shown to act as boronic acid equivalents in 
palladium-catalyzed Suzuki-Miyaura couplings[8]. However, our research is focused on the 
development of metal-free reactions of organotrifluoroborates. Metal-free transformations 
of organotrifluoroborates are becoming increasingly prevalent due to the cost and toxicity 
associated with transition metals[9]. Namely, Lewis acid-catalyzed reactions have emerged 
as an alternative to metal-catalyzed protocols. 
 
1.1.2.1 LEWIS ACID-CATALYZED REACTIONS OF 
TRIFLUOROBORATES 
 
  In 2002, Matteson and coworkers developed a mild and efficient route to the 
synthesis of asymmetric secondary amines via an intramolecular reaction between azides 
and alkyltrifluoroborates (Scheme 3). In this method, the Lewis acidic tetrachlorosilane 
defluorinates the alkyltrifluoroborate salt to yield the reactive alkyldifluoroborane 
intermediate[10]. 
 
Scheme 3: Lewis acid-catalyzed reaction of azide and difluoroborane intermediate 
 
More recently, our group has described a straightforward method for the 
preparation of ynones from acyl chlorides and alkynyltrifluoroborate salts in the presence 
of a Lewis acid (Scheme 4). Reactive organodichloroborane intermediate is formed upon 






Scheme 4: Lewis acid-catalyzed alkynylation of acyl chlorides 
 
 Our group was then able to employ a similar BCl3 catalyzed protocol for the 
synthesis of sterically hindered ortho-demethylated ynones from mixed anhydrides and 
potassium alkynyltrifluoroborate salts (Scheme 5). The 2-hydroxy substituted ynone 
products were then converted to biologically active natural product scaffolds[12]. 
 
Scheme 5: Lewis acid-catalyzed preparation of sterically hindered ynones and their 
application to the synthesis of aurones and flavones 
 
  Additionally, organotrifluoroborates have also been shown to react with boron 
trifluoride (BF3·OEt2). In 2009, Bode and coworkers developed a method for the synthesis 
of dialkyl ethers from O-methoxymethyl (MOM) acetals and aryl-, alkenyl- or 
alkynyltrifluoroborate salts (Scheme 6) [13]. In this method, interaction of trifluoroborate 
with BF3·OEt2 resulted in the formation of Lewis acidic organodifluoroborane species. 
Although this reaction tolerated aryl-, alkenyl- and alkynyltrifluoroborates, electron-




to improve the reaction conditions through the use of a hydroxamate leaving group. This 
resulted in improved regioselectivity of challenging substrates, higher yields of the dialkyl 
ether products, reduction of the equivalents of Lewis acid and organotrifluoroborate as well 
as allowed for electron-withdrawing (hetero)-aryls to be present[14]. 
 
Scheme 6: Lewis acid-catalyzed synthesis of dialkyl ethers from organo-
trifluoroborates and acetals 
 
 Stefani and coworkers developed a highly stereoselective and mild method for the 
C-glycosidation of 3,4,6-tri-O-acetyl-ᴅ-glucal with alkynyltrifluoroborates (Scheme 7). 
This reaction was mediated by BF3·OEt2 Lewis acid. They proposed that reaction of BF3 
and alkynyltrifluoroborate facilitates the generation of the organodifluoroborane Lewis 
acid. Activation of 3,4,6-tri-O-acetyl-ᴅ-glucal with organodifluoroborane results in the 
formation of an oxocarbenium ion and a nucleophilic tetracoordinated boron species. 
Attack at the C-1 position resulted in the formation of a variety of α-C-glycosides[15]. 
 
Scheme 7: Lewis acid-catalyzed synthesis of α-C-glycosides from potassium 





 Liu and coworkers were also able to employ a BF3·OEt2 mediated C-glycosylation 
approach through the coupling of organotrifluoroborates and glycosyl fluorides (Scheme 
8). Alkenyl and alkynyl C-glycosides were obtained in good to excellent yields with high 
diastereoselectivity[16]. 
 
Scheme 8: Lewis acid-catalyzed direct C-glycosylation of glycosyl fluorides with 
organotrifluoroborates 
 
1.1.2.1.1 REACTIONS OF ORGANODICHLOROBORANES WITH 
BENZHYDRYL ALCOHOLS 
 
 In 2006, Kabalka and coworkers have shown that the substitution of hydroxyl 
groups of benzhydryl alcohols can occur using alkynylboron dihalides[17] (Scheme 9). They 
reported a novel method for directly converting aryl and aliphatic alkynes to the 
corresponding alkynylboron dichlorides without the necessity to pre-form 
alkynyltrifluoroborates. Migration of the alkynyl group from boron to carbon occurs 
forming a variety of internal acetylenes in moderate to excellent yields. 
 
 






 In summary, metal-free Lewis acid-catalyzed reactions of organotrifluoroborates 
have been extensively studied. However, the limitations of these protocols include the 
necessity to preform unstable boron dihalide intermediates thereby resulting in a narrow 
substrate scope. 
1.1.2.2 REACTIONS OF TRIFLUOROBORATES WHICH OCCUR IN THE 
PRESENCE OF BRØNSTED ACIDS 
 
 Contrary to the previously outlined methods for the Lewis acid-catalyzed reactions 
of organotrifluoroborates, Brønsted acid catalyzed reactions of organotrifluoroborates are 
uncommon. A literature survey only resulted in the findings that organotrifluoroborates 
have been shown to participate in reactions whereby Brønsted acids are present.  
In the reaction shown by MacMillan and coworkers, vinyl and heteroaryl 
trifluoroborate salts were viable substrates for amine-catalyzed conjugate additions[18]. 
They found that exposing crotonaldehyde to organotrifluoroborates in the presence of an 
imidazolidinone catalyst and hydrofluoric acid resulted in the formation of the desired 
aldehyde products (Scheme 10). The authors suggest that the presence of HF is necessary 
for the sequestration of boron trifluoride by-product, by forming a BF4K precipitate, which 
they confirmed by 19F NMR. Notably, HF has been used for the preparation of 
trifluoroborate salts. Therefore, it may also act as a stabilizing agent for the 
trifluoroborates.
 
Scheme 10: Organocatalytic conjugate addition of trifluoro(organo)borates to α,β-





In 2013, Carreira and coworkers showed an iridium-catalyzed asymmetric 
substitution reaction of allylic alcohols with vinyl trifluoroborates (Scheme 11). Although 
catalyzed by an Ir-(P,olefin) complex, the reaction took place in the presence of 2.0 
equivalents a Brønsted acid, HF. Interestingly, in this case the authors suggested that HF 
was present as a trifluoroborate activator[ 19 ]. Later on, they showed that direct 
enantioselective substitution of allylic alcohols was possible with 
alkynyltrifluoroborates[20]. Notably, they were able to avoid the use of hazardous and 
corrosive HF in this protocol by using KHF2 as an alternative fluoride source. Through the 
use of KHF2 and CF3COOH, they were able to generate HF in situ. 
 
Scheme 11: Iridium-catalyzed enantioselective allylic vinylation using allylic alcohols 
and alkenyltrifluoroborates in the presence of a Brønsted acid 
 
 Aggarwal and coworkers reported the allylation-like addition of trifluoroborates to 
aldehydes in the presence of trifluoromethanesulfonic acid (Scheme 12). However, 
although a Brønsted acid was used, the procedure was mechanistically similar to Lewis 
acid-catalyzed transformations since a difluoroborane intermediate was formed[21]. 
 





 1.2 RESEARCH OBJECTIVE 
 
  At the outset, we wanted to develop a set of metal-free Brønsted acid catalyzed 
reactions of organotrifluoroborates. By doing this, we would hopefully avoid issues 
associated with typical Lewis acid-catalyzed protocols, which involve the generation of 
unstable boron dihalide species. By avoiding the generation of Lewis acidic intermediates, 
there was promise to extend the substrate scope beyond ether, halide and alkyl substituents.  
 Inspired by the work described by Kabalka and coworkers (Section 1.1.2.1.1), we 
proposed that activation of benzhydryl alcohols could instead be accomplished via a 
Brønsted acid. Subsequently, in the presence of a nucleophilic organotrifluoroborate, 
reaction at the benzhydryl center could be possible. Unlike Lewis acidic boron dihalides, 
organotrifluoroborates do not need to be activated since they already have a 












1.3 BENZHYDRYL SCAFFOLDS 
 
  Development of methods for the synthesis of compounds which contain benzhydryl 
scaffolds are synthetically useful. Namely, the diphenylmethane scaffold is prevalent in 
natural products, bioactive compounds and several pharmaceuticals. The following Figure 
3 illustrates three prescription pharmaceuticals present in the market which contain the 
benzhydryl scaffold. 
 
Figure 3: Benzhydryl scaffolds present in pharmaceuticals 
 
 
1.3.1 SYNTHESIS OF BENZHYDRYL COMPOUNDS 
 
1.3.1.1 METAL-CATALYZED REACTIONS OF BENZHYDRYL ALCOHOLS
  
Several protocols have been described for the functionalization of benzhydryl 
centers[ 22 ]. However, direct metal-catalyzed dehydrative coupling reactions involving 
diarylmethanols have recently gained attention for several reasons. Firstly, a vast amount 
of diarylmethanol derivatives are commercially available or can be easily prepared. 





 In 2009, Jiao and coworkers developed a sp-sp3 carbon-carbon bond forming 
methodology between terminal alkynes and benzhydryl alcohols via a Fe(OTf)3/TfOH co-
catalyzed coupling reaction[24]. In this protocol, water was the sole byproduct (Scheme 13). 
 
 
Scheme 13: Metal-catalyzed dehydrative coupling of benzhydryl alcohols with 
terminal alkynes 
 
As well, metal-catalyzed alkenylation of benzhydryl alcohols are known[ 25 ]. 
Specifically, Gandon and coworkers have shown that the direct alkenylation of a variety of 
alcohols, including benzhydrols, occurs in the presence of 2.0 equivalents of vinylboronic 
acids through the use of a Ca(NTf2)2 catalyst
[26] (Scheme 14). 
 
 
Scheme 14: CaII-catalyzed alkenylation of benzhydryl alcohols with vinylboronic 
acids 
However, several disadvantages are present for these metal-catalyzed approaches. 
Specifically, these protocols oftentimes require the use of expensive, sensitive and toxic 







1.3.1.2 METAL-FREE REACTIONS OF BENZHYDRYL ALCOHOLS  
 
  To avoid these limitations, metal-free reactions of benzhydryl alcohols is of 
interest. Previously mentioned in Section 1.1.2.1.1, Kabalka and coworkers demonstrated 
that the substitution of hydroxyl groups of benzhydryl alcohols can occur using 
alkynylboron dihalides[17] (Scheme 9).  They have also developed a similar metal-free 
methodology using benzhydryl alcohols and pre-formed alkenylboron dihalides[ 27 ] 
(Scheme 15). In both cases, the use of n-BuLi as well as the necessity to form unstable 
boron dihalide intermediates resulted in a narrow substrate scope. 
 
Scheme 15: Metal-free substitution of benzylic hydroxyl groups with vinyl moieties 
using vinylboron dihalides 
  
 Other methods for the alkenylation of benzhydryl alcohols under metal-free 
conditions are known[28]. However, of interest, Schaus and coworkers illustrated that the 
enantioselective addition of alkenylboronates to benzhydryl alcohols and ethers occurs via 
a chiral biphenol catalyst[29] (Scheme 16). However, the necessity to use 2.0 equivalents of 
unstable alkenylboronates and the requirement of a 2-hydroxy substituted benzhydryl 





Scheme 16: Enantioselective addition of boronates to benzhydryl alcohols and ethers 
catalyzed by chiral biphenols 
  Although methods for the alkenyl- and alkynylation of benzhydryl alcohols under 
metal-free conditions are known, an operationally simple method, which avoids the use of 
n-BuLi, the necessity to pre-form unstable boron dihalide intermediates and avoid the use 
of unstable starting materials has not been developed. Furthermore, narrow substrate 
scopes for a number of these methods is observed. 
 
1.3.1.3 METAL-FREE REACTION OF BENZHYDRYLIUM ION AND 
ORGANOTRIFLUOROBORATE 
 
 In 2012, Mayr and coworkers conducted a study which looked at determining the 
relative nucleophilicity of organoboron compounds in comparison with related 
nucleophiles[4a]. In this paper, they were able to show a single example of a pre-formed 
benzhydrylium carbocation reacting with a single potassium 5-methylfuran-2-
yltrifluoroborate in the absence of a catalyst (Scheme 17).  
 
Scheme 17: Transition metal-free C-C bond forming reaction of organo-




1.4 α-FUNCTIONALIZED CYCLIC ETHER SCAFFOLDS 
  
  In addition to benzhydryl scaffolds, application of a Brønsted acid-catalyzed 
reaction of organotrifluoroborates towards the synthesis of ether scaffolds was also of 
interest. Ethers are an important functional group in organic chemistry as they are found 
among several bioactive compounds and pharmaceutical agents[30]. Tetrahydrofuran (THF) 
and tetrahydropyran (THP) rings are being increasingly observed in structures of new 
bioactive compounds and natural products[31]. Additionally, several bioactive molecules 
which contain α-functionalized cyclic ethers are known[32] (Figure 4). 
 
Figure 4: Bioactive molecules which contain α-functionalized cyclic ethers 
 
1.4.1 METHODS FOR THE SYNTHESIS OF α-FUNCTIONALIZED 
TETRAHYDROFURANS AND TETRAHYDROPYRANS 
 
 C-glycosides are present in a number of natural products and enzymatically stable 
analogs of pharmaceutical importance. As a result, a number of protocols for their 
preparation has increased over the past several decades[33]. Namely, the carbon-carbon 
glycosidic bond shows an increased stability toward chemical and/or enzymatic hydrolysis. 




bonds is of interest. Specifically, the synthesis of 2-alkenyl and 2-alkynyl tetrahydrofurans 
and tetrahydropyrans haven been explored. 
  Ley and coworkers have shown that a direct substitution of 2-benzenesulfonyl 
cyclic ethers occurs by treatment with the corresponding organozinc reagents to afford 
alkynylated products (Scheme 18). Both 2-(phenylsulfonyl)tetrahydropyrans and 2-
(phenylsulfonyl)tetrahydrofurans participated in the transformations[34]. 
 
Scheme 18: Direct substitution of 2-benzenesulfonyl cyclic ethers using organozinc 
reagents 
 
 Later in 2004, Ley and coworkers demonstrated that anomeric oxygen to carbon 
rearrangements of alkynylstannane derivatives of furan and pyran rings occurs in the 
presence of a BF3·OEt2 Lewis acid (Scheme 19). This rearrangement resulted in the 
formation of the corresponding carbon linked alkynol products[35].  
 
Scheme 19: Rearrangements of alkynylstannane derivatives of furan and pyran rings 
catalyzed by BF3·OEt2 
  
In 1996, Fuchs and coworkers showed that the alkynylation of C-H bonds occurs 
via reaction of THF or THP with acetylenic triflones[36]. Alkynylated furan and pyran 
derivatives were obtained in good to excellent yields (Scheme 20). The C-H 






Scheme 20: Alkynylation of C-H bonds via reaction with acetylenic triflones 
 
Several additional methods for the synthesis of 2-alkenyl and 2-alkynyl 
tetrahydrofurans and tetrahydropyrans have been explored. However, all of these methods 
occur through tetrahydrofuranyl and tetrahydropyranyl α-oxy radical intermediates similar 
to the method described above[38]. 
 Also, Anderson and coworkers were able to prepare 2-alkynyl tetrahydrofurans and 
tetrahydropyrans from cyclic and acyclic carbonates (Scheme 21). These cyclizations were 
achieved through the use of palladium catalysts[39]. 
 
Scheme 21: Palladium-catalyzed cyclizations of cyclic and acyclic carbonates 
 
 In addition, when looking at methods for the synthesis of 2-alkenyl and 2-alkynyl 
tetrahydrofurans and tetrahydropyrans, the use of boron-based compounds is limited. 




cyclization of free allylic alcohols (Scheme 22). Mechanistic studies suggested that 
complete or near-complete ionization of allylic alcohols into allylic carbocation 
intermediates occurs when exposed to the boronic acid catalyst[40]. 
 
Scheme 22: Boronic acid catalyzed heterocyclizations of allylic alcohols 
 
 Additionally, Liu and coworkers illustrated that organotrifluoroborates and trityl 
ions can be used for the C-H functionalization of THF (Scheme 23). Trityl salts were 
generated by exposing trityl chlorides to GaCl3 Lewis acid. This method was tolerant to 
alkenyl, alkynyl and aryltrifluoroborates. Mechanistic studies suggested that for THF and 
other saturated ethers, the trityl ion functioned as a hydride acceptor[41]. 
 
Scheme 23: C-H functionalization of THF using trifluoroborates and trityl ions 
  
  Although there are several protocols, which describe the preparation of these 
desired products, the necessity to use expensive metal catalysts, stoichiometric amounts of 
Lewis acid as well as sensitive reagents is what hinders the practicality of these methods. 
As a result, we wanted to develop an operationally simple protocol involving a metal-free 




1.4.2 METAL-FREE REACTIONS OF TRIFLUOROBORATES 
(CONTINUED) 
 
 In addition to the methods described in Section 1.1.2 regarding metal-free reactions 
of trifluoroborates, our group recently developed a Brønsted-acid catalyzed methodology 
for the alkynylation of acetals and ketals with alkynyltrifluoroborates (Scheme 24). After 
the findings, which are described in the following Chapter 3 were obtained[42], this protocol 
for the preparation of propargylic ethers was developed as an extension of the substrates, 
which reacted under similar Brønsted acid-catalyzed conditions[43]. Similar to Lewis acid 
catalyzed methods shown by Bode[13,14] and Stefani[15], this Brønsted acid-catalyzed 
transformation was also proposed to occur through an oxocarbenium ion intermediate. 
 
Scheme 24: Brønsted acid-catalyzed alkynylation of acetals and ketals with 
alkynyltrifluoroborates 
 
 In showing that the alkynylation of acetals and ketals occurs via a Brønsted acid 
catalyst, we wanted to probe at similar scaffolds, which could undergo an analogous 
transformation. Therefore, we envisioned that the synthesis of α-functionalized ethers 
could be possible if the described methodology could be extended to tetrahydrofuranyl 







 2. EXPERIMENTAL METHODS 
 
2.1 GENERAL SYNTHETIC METHODS 
 
  All reactions were set up in 2 dram glass vials at room temperature under air. Unless 
otherwise noted, all other reagents and materials were obtained from commercial suppliers 
and used without further purification. Potassium trifluoroborate salts were synthesized 
according to published procedures[11,15,42,43,44]. Reaction progress was monitored via thin 
layer chromatography (TLC) on silica gel (60 Å) with visualization using ultraviolet light 
(254 nm) and by staining with potassium permanganate (KMnO4) or phosphomolybdic 
acid (PMA). NMR characterization data was collected at 25oC on an Oxford AS400 NMR 
as solutions in deuterated solvents (CDCl3, acetone-d6 and DMSO-d6 obtained from 
Cambridge Isotope Laboratories, Inc.). 1H and 19F NMR spectra were collected at 400 and 
376 MHz, respectively, while 13C {1H} and 11B {1H} NMR spectra were collected at 100 
and 128 MHz, respectively. Chemical shifts are expressed in ppm values. IR spectra were 
recorded on a Bruker ALPHA-P FTIR spectrometer using a platinum ATR with a diamond 
ATR crystal. Spectra are reported in terms of frequency of absorption (cm-1) and only 
partial data is provided. Melting points were measured with a melting point apparatus and 
are uncorrected. High resolution mass spectra (HRMS) were recorded using electrospray 
ionization (ESI), electron impact ionization (EI), direct analysis in real time (DART) ion 
source, and time-of-flight (TOF) mass analysis. Automated flash chromatography was 
conducted using a Biotage Isolera flash chromatography system using silica gel (60 Å, low 








2.2 SYNTHESIS OF POTASSIUM 
ALKYNYLTRIFLUOROBORATE SALTS 
 




General Procedure 1: To a solution of the indicated terminal alkyne (1.0 equiv.) in dry 
THF at −70 °C under argon atmosphere was added either n-BuLi or t-BuLi (1.0 equiv.) 
dropwise, and the solution was stirred for 1 h at this temperature. Trimethylborate (1.5 
equiv.) was added dropwise at −60 °C. The solution was stirred at this temperature for 2 h. 
A saturated aqueous solution of KHF2 (6.0 equiv.) was added at −20 °C. The mixture was 
allowed to stir for 1 h at −20 °C and for 1 h at room temperature. The solvent was removed 
under reduced pressure, and the resulting solid was placed under vacuum overnight to 
remove any remaining water. The solid was washed several times with hot acetone (4 × 10 
mL), which was collected and concentrated to a volume of ∼10 mL. The product was 
precipitated with diethyl ether (30 mL) and cooled to 4 °C to complete precipitation. The 
crystalline solids were collected by gravity filtration and further dried under vacuum to 















2.3 SYNTHESIS OF POTASSIUM (E)-
ALKENYLTRIFLUOROBORATE SALTS 
 
 Potassium (E)-alkenyltrifluoroborate salts were prepared according to a procedure 
modified from Molander and coworkers[44]. 
 
General Procedure 2: To a solution of the indicated boronic acid (1.0 equiv.) in Et2O (6 
mL) was added KHF2 (2.8 equiv.), followed by H2O (2.7 mL) over a period of 30 min. 
After stirring at rt for 3 h, the solvent was removed under reduced pressure, and the 
resulting solid was placed under vacuum overnight to remove any remaining water. The 
solid was washed several times with hot acetone (4 × 10 mL), which was collected and 
concentrated to a volume of ∼10 mL. The product was precipitated with diethyl ether (30 
mL) and cooled to 4 °C to complete precipitation. The crystalline solids were collected by 
gravity filtration and further dried under vacuum to afford (E)-alkenyltrifluoroborate salts 
2a-d (Figure 6). 
 




2.4 SYNTHESIS OF BENZHYDRYL ALCOHOLS 
 
 
General Procedure 3: A solution of the indicated benzaldehyde (1.0 equiv.) in dry THF 
was treated with the indicated phenylmagnesium bromide solution (1.1-4.0 equiv.) at 0 °C. 
After addition was complete, the mixture was allowed to stir at room temperature for 
30−120 min. The reaction was quenched with aqueous 1 M HCl solution and extracted 
with 50 mL of EtOAc. The organic layer was washed with water (3 × 30 mL) followed by 
brine (1 × 25 mL). The organic layer was dried with MgSO4 and concentrated. Purification 
by flash chromatography with hexanes/ethyl acetate afforded products 3a-i (Figure 7). 
 





2.5 SYNTHESIS OF INTERNAL ALKENES AND ALKYNES 
 
 
General Procedure 4: In a 2 mL vial containing a stir bar, the indicated benzhydrol alcohol 
(1.0 equiv.) and potassium trifluoroborate salt (1.0 equiv.) were added followed by addition 
of anhydrous acetonitrile (0.3 mL). HBF4·OEt2 (1.3-2.6 equiv.) was added dropwise, and 
the reaction was allowed to stir at room temperature for 15 min. The reaction was quenched 
with water and extracted in 20 mL of ethyl acetate. The organic layer was washed with 
water (3 × 15 mL) followed by brine (1 × 10 mL). The organic layer was dried with MgSO4 
and concentrated. The products were purified by flash chromatography with hexanes/ethyl 
acetate. In the cases where a CH3CN/hexanes extraction was required, the product was 
solubilized in 5 mL of anhydrous acetonitrile in a 20 mL vial. Then, 1 mL of hexanes was 
added, forming a bilayer. The two layers were thoroughly mixed and then allowed to settle. 
The bottom acetonitrile layer was then removed and concentrated to afford the product. In 
the cases where a pentane wash was required, in a minimum of chloroform, the product 











2.6 PROCEDURE FOR THE DEMETHYLATION OF 7 
 
Phenol 8 was prepared according to a procedure modified from Hanson and coworkers[45]. 
 
General Procedure 5: A solution of the indicated ortho-methoxy-substituted product 7 
(1.0 equiv.) in dry DCM (0.1 M) was treated with boron tribromide solution (3.0 equiv.) at 
0 °C. After addition was complete, the mixture was allowed to stir at room temperature for 
30 min. The reaction was quenched with water and extracted with 20 mL of EtOAc. The 
organic layer was washed with water (3 × 15 mL) followed by brine (1 × 10 mL). The 
organic layer was dried with MgSO4 and concentrated. The product was purified by flash 
chromatography with hexanes/ethyl acetate and concentrated. Further purification via a 










2.7 CYCLIZATION OF INTERNAL ALKYNE 8 
 
Benzofuran 9 was prepared according to a procedure by Luo and coworkers[46]. 
 
 
General Procedure 6: The indicated ortho-hydroxy-substituted product 8 (1.0 equiv.) was 
dissolved in anhydrous dioxane. Then, potassium tert-butoxide (2.0 equiv.) was added, and 
the reaction mixture was stirred at ambient temperature for 1.75 h. The reaction solution 
was then diluted with DCM (10 mL) and washed with brine (10 mL). The aqueous phase 
was extracted with DCM (2 × 10 mL). The combined organic phase was washed with water 
(3 × 15 mL) and brine (1 × 10 mL). The organic layer was dried with MgSO4 and 
concentrated. The product was purified by flash chromatography with hexanes/diethyl 
ether and concentrated. Further purification via a CH3CN/hexanes extraction afforded the 








2.8 SYNTHESIS OF 2-ALKENYL AND 2-ALKYNYL 




General Procedure 7: In a 2 dram vial containing a stir bar, the indicated potassium 
trifluoroborate salt (1.5 equiv.) was added at room temperature followed by the addition of 
anhydrous acetonitrile (C = 0.1 M). The indicated THF or THP (1.0 equiv.) was then added 
to the solution, and the solution was stirred at -10oC for 5 minutes. HBF4∙OEt2 (1.5 equiv.) 
was added to the stirring solution at -10oC. The solution was stirred at this temperature for 
15 minutes. The reaction was quenched with water and extracted with 20 mL of ethyl 
acetate. The organic layer was washed with water (3 x 15 mL) followed by brine (1 x 10 
mL). The organic layer was dried with MgSO4 and concentrated. The crude product was 
purified by flash chromatography and concentrated. In the cases where a CH3CN/hexanes 
extraction was required, the product was solubilized in 5 mL of acetonitrile and 1 mL of 
hexanes was added forming a bi-layer. The two layers were thoroughly mixed and cooled 
to 0oC in an ice bath to promote separation. The bottom acetonitrile layer was then removed 
and the extraction was performed again on the same hexanes layer. The acetonitrile 









 3. METHODOLOGY DEVELOPMENT FOR 
THE ALKENYLATION AND ALKYNYLATION 
OF BENZHYDRYL ALCOHOLS WITH 
ORGANOTRIFLUOROBORATES 
 
3.1 METHODOLOGY DEVELOPMENT 
 
3.1.1 OPTIMIZATION OF REACTION CONDITIONS 
 
  Our initial efforts were focused on the preparation of secondary alkylacetylene 4a 
from potassium phenylacetylenetrifluoroborate salt 1a and commercially available 
diphenylmethanol (Table 1). After careful consideration, we chose to use tetrafluoroboric 
acid (HBF4) as the catalyst. With a pKa of 0.5 in water
[47], this Brønsted acid has been 
shown to be strong enough to promote the formation of benzhydrylium carbocations from 
diarylmethanols[48]. Additionally, this Brønsted acid has a non-nucleophilic counter ion 
(BF4ˉ) which will not react with the benzhydrylium carbocation once it is generated. 
We initially began with a screen of solvents and found that the desired product 4a 
was not formed in DCM (Table 1, entry 1) and DMSO (Table 1, entry 2). Alternatively, 
we found that when CH3CN was used as the solvent, the reaction yielded alkyne 4a solely 
in 35% yield (Table 1, entry 3). 
 We then focused our attention on determining the optimal equivalents of each 
starting material. We found that a slight excess of either diphenylmethanol (Table 1, entry 
4) or potassium phenylacetylenetrifluoroborate salt (Table 1, entry 5) resulted in the 























1 1.0 1.0 HBF4·OEt2 1.0 DCM trace  
2 1.0 1.0 HBF4·OEt2 1.6 DMSO trace  
3 1.0 1.0 HBF4·OEt2 1.0 CH3CN 35 1:0 
4a 1.2 1.0 HBF4·OEt2 1.0 CH3CN  4:3 
5a 1.0 1.2 HBF4·OEt2 1.0 CH3CN  2:1 
6a 1.0 1.0 HBF4·OEt2 0.5 CH3CN  1:1 
7 1.0 1.0 HBF4·OEt2 1.2 CH3CN 37 25:1 
8 1.0 1.0 HBF4·OEt2 1.4 CH3CN 37 1:0 
9 1.0 1.0 HBF4·OEt2 1.6 CH3CN 41 1:0 
10 1.0 1.0 HBF4·OEt2 1.8 CH3CN 36 1:0 
11 1.0 1.0 HBF4·OEt2 2.0 CH3CN 34 1:0 
12 1.0 1.0 4.0 M HCl 1.6 CH3CN trace  
13 1.0 1.0 HSbF6·6H2O 1.5 CH3CN trace  
14b 1.0 1.0 HBF4·OEt2 1.6 CH3CN 36 1:0 
15c 1.0 1.0 HBF4·OEt2 1.6 CH3CN  N/A 
16d 1.0 1.0 HBF4·OEt2 1.6 CH3CN 34 1:0 
17e 1.0 1.0 HBF4·OEt2 1.6 CH3CN 25 20:1 
 
aThe ratio has been determined by NMR analysis of crude reaction mixtures. bReaction run at 0oC. 
cReaction run at 40oC. Product and unidentified by-product synthesized. dAnhydrous conditions. 





  Next, we looked at the effect of the acid catalyst loading on the reaction. Initially, 
we observed that using a substoichiometric amount of HBF4 resulted in the formation of a 
50/50 mixture of 4a and 13 (Table 1 , entry 6). By gradually increasing the amount of 
HBF4, we observed that the yield of the desired product 4a was increasing, and that the 
formation of the undesired dibenzhydryl ether byproduct 13 was suppressed (Table 1, 
entries 7, 8). These observations were consistent with the findings that increasing the 
equivalents of HBF4 results in inhibition of the formation of the dimer byproduct 13
[48]. In 
further increasing HBF4 to 1.6 equivalents, we obtained a 41% yield of 4a (Table 1, entry 
9). Additional gradual increases in the amount of HBF4 resulted in a decrease in product 
formation (Table 1, entries 10-11). 
 Efforts were then focused on seeing if alternative Brønsted acids could catalyze the 
reaction. HCl was initially tried since it could be purchased as an anhydrous solution in 
dioxane. This was important since the HBF4 acid was purchased as an anhydrous complex 
with diethyl ether. However, only trace amounts of product was formed when HCl was 
used (Table 1, entry 12). Work-up NMR indicated that chlorodiphenylmethane emerged as 
a byproduct due to the competing reaction of the nucleophilic Clˉ anion with the 
benzhydrylium carbocation. Consequently, we realized that having an acid with a non-
nucleophilic counter ion was important. As a result, we then wanted to see if HSbF6·6H2O 
could catalyze the reaction. This acid, like HBF4, also contains a non-nucleophilic counter 
ion (SbF6ˉ) which should not react with the benzhydrylium carbocation. However, this acid 
also only allowed for the formation of trace amounts of product 4a to form (Table 1, entry 
13). In this case, however, the starting material was not consumed. Neither the product nor 
the byproduct were observed.  
  With the tentatively optimized conditions at hand (Table 1, entry 9), we then 
focused our attention on manipulation of other reaction variables (Table 1, entries 14-17). 
With the reaction occurring within fifteen minutes at room temperature, we wanted to see 
the effect of reduced temperature. We observed that running the reaction at 0oC (Table 1, 
entry 14) resulted in the disappearance of diphenylmethanol within thirty minutes, 
however, the yield decreased by 5%. We then wanted to see the effect of running the 




15), diphenylmethanol starting material disappeared within fifteen minutes, however, this 
resulted in the formation of an inseparable mixture of product 4a and a new unidentified 
byproduct. Interestingly, the yield decreased from 41% to 34% when the reaction flask was 
dried and the reaction was conducted under argon (Table 1, entry 16). We then looked to 
see what the effect was of adding a controlled quantity of water. The yield decreased 
dramatically to 25% of product 4a and trace amounts of the dibenzhydryl ether byproduct 
13 was formed when 1.5 equivalents of water was introduced (Table 1, entry 17). 
 
3.1.2 INVESTIGATION INTO THE ORDER OF ADDITION OF 
REAGENTS 
 
  The order of addition of reagents in this method was deemed to be very important. 
Initially, 4-methylbenzhydrol and potassium phenylacetylenetrifluoroborate salt 1a were 
pre-stirred in acetonitrile for one minute at room temperature. No evidence of a reaction 
between the two starting materials was observed on TLC in the absence of the acid catalyst. 
Once HBF4 was added, the reaction solution turned from a colourless transparent solution 
to bright yellow solution, which was translucent. Product formation was clearly evident on 
TLC. When the order of addition was changed, the reaction did not result in significant 
product formation (Scheme 25). 
 
 





  When potassium phenylacetylenetrifluoroborate salt and HBF4 were pre-mixed, 
which was followed by the addition of 4-methylbenzhydrol, the reaction resulted in trace 
amounts of product 4b. Several byproducts were observed on TLC. It turned out that 
potassium phenylacetylenetrifluoroborate salt 1a decomposed in the presence of HBF4. 
This was confirmed by a set of NMR studies (Figure 8 and Appendix III). Firstly, in 
deuterated acetonitrile solvent (CD3CN), potassium phenylacetylenetrifluoroborate salt 1a 
shows a signal at -134.90 ppm in a 19F NMR (Figure 8, NMR A). HBF4 shows a signal at 
-150.49 ppm (Figure 8, NMR B). Then, potassium phenylacetylenetrifluoroborate salt 1a 
and HBF4 were mixed in CD3CN in an NMR tube and a 
19F NMR of the mixture was taken 
immediately. We observed that the fluorine peak of the potassium phenylacetylene-
trifluoroborate salt 1a had disappeared but that the fluorine peak for HBF4 was still 
observed (Figure 8, NMR C). From looking at the proton and carbon NMRs of this reaction 
mixture, characteristic peaks from phenylacetylene were observed (see Appendix III for 
additional spectra). Therefore, we propose that when potassium phenylacetylene-
trifluoroborate salt is exposed to HBF4 in the absence of 4-methylbenzhydrol, 
protodeboronation occurs. As a result of the decomposition, the reaction does not take place 

















HBF4·OEt2 HBF4·OEt2 + 
trifluoroborate 1a 
 
Figure 8: 19F NMR study of potassium phenylacetylenetrifluoroborate 1a and 
HBF4·OEt2 in CD3CN 




 Similarly, when potassium phenylacetylenetrifluoroborate 1a was added to a 
mixture of 4-methylbenzhydrol and HBF4, only trace amounts of desired product 4b were 
observed on TLC (Scheme 25). After leaving the reaction for several hours, a significant 
amount of 4-methylbenzhydrol was still observed on TLC and only a faint product spot 
had appeared. After no change in the TLC after several hours, this illustrated that pre-
mixing 4-methylbenzhydrol and HBF4 was not advantageous.  
 Therefore, we found that it was imperative to add the HBF4 catalyst as the last 
reagent in order for significant formation of the desired product. 
 
3.2 PROPOSED MECHANISTIC PATHWAY 
Illustrated in the following Scheme 26 is our proposed mechanistic pathway for the 
formation of internal alkenes and alkynes. We suggest that a Brønsted acid would protonate 
the hydroxyl group of the benzhydryl alcohol (I). Subsequently, the protonated alcohol, 
will dissociate in the form of a water molecule from the diphenylmethane compound (II) 
thus generating the benzhydrilum ion (III). The nucleophilic trifluoroborate present in the 
solution will then react with the electrophilic center, thus forming the final product (IV). 
 





3.3 RESULTS AND DISCUSSION 
  
  With the developed reaction conditions at hand, our next step was to look at the 
scope of benzhydryl alcohols and organotrifluoroborate salts that are capable of 
participating in the reaction. 
 
3.3.1 REACTIONS OF PHENYLACETYLENETRIFLUOROBORATE 
SALT WITH BENZHYDRYL ALCOHOLS 
 
 Initial investigation into the substitution effects revealed that benzhydryl alcohols 
containing electron-donating substituents resulted in higher yields of the desired products 
as compared to when electron-withdrawing substituents were present (Figure 9). As 
previously discovered, when unsubstituted benzhydrol was used, product 4a was obtained 
in 41% yield. Furthermore, the yield of 4b was 67% when an electron-donating 4-methyl 
substituent was present. The reaction exhibited mild sensitivity to the steric hindrance. 






Figure 9: Reactions of phenylacetylenetrifluoroborate salt with benzhydryl alcohols. 
aUsing 1.3 equiv of HBF4 
 
The yield further increased when stronger electron-donating 4-methoxy group was 
present. Product 4d was obtained in excellent 87% yield. Notably, a scale-up reaction 
afforded 0.20 g of 4d with a yield erosion of only 10%. Product 4e was obtained in an even 
higher 91% yield when two methoxy groups were present in the para-positions. 




chloro group was present. We propose that destabilization of the carbocation intermediate 
occurs in the presence of electron-withdrawing groups. As a result, several unidentified 
byproducts were observed. 
 Next, we then wanted to explore into whether the destabilizing electron-
withdrawing effect of one substituent in the 4-position could be off-set if an electron-
donating group was present in the 4’-position. When (4-chlorophenyl)(4-
methoxyphenyl)methanol was used, product 4g was obtained in excellent 84% yield. 
Seemingly, the negative effect of an electron-withdrawing group can be overcome by 
applying this method. 
Furthermore, we were pleased see that we were able to expand the scope to 
unprotected protic functional groups. Free phenol- and amide-containing substrates 
afforded products 4h and 4i in 66 and 61% yields, respectively. When a carboxylic acid 
functional group was present, modest 42% yield of 4j was observed. However, we 
proposed that the carboxylic acid moiety could act as a source of protons during the 
reaction. As a result, we thought that in combination with the HBF4 acid catalyst, excessive 
amounts of acid present could have been responsible for the poor yield of 4j. Consequently, 

















3.3.2 REACTIONS OF VARIOUS ALKYNYLTRIFLUOROBORATES 
WITH BENZHYDRYL ALCOHOLS 
 
  Next, we looked to investigate into the scope of potassium alkynyltrifluoroborate 
salts that were tolerant to this method (Figure 10). A wide range of 
phenylacetylenetrifluoroborate salts that contained trifluoromethyl, chloro and fluoro 
functional groups acted as sufficient coupling partners to afford the desired products 5a-5e 
in excellent yields. Notably, product 5e was obtained in 82% yield when an unprotected 
aldehyde group was present on the benzhydryl alcohol. Furthermore, unsubstituted 
biphenyl- and naphthylacetylenetrifluoroborates afforded the desired products (5f-5h) in 
good yield.  
  We then looked to examine other substituents which were tolerant to the 
methodology. More specifically, we were able to expand the substrate scope to benzhydryl 
alcohols, which contained an amine functional group. The presence of a dimethylamine 
functional group resulted in a modest 53% yield of 5i. In the presence of acid, the basic 
amine functional group could undergo protonation. As a result, we decided to increase the 
acid-to-substrate ratio with the expectation of obtaining an increased product yield. With 
the addition of 2.6 equivalents of HBF4 (one equivalent more than the usual acid loading), 
we were able to improve the yield of 5i to 61%. We then applied the same conditions to a 
benzhydryl alcohol, which contained a Boc-protected amine. We obtained a 51% yield of 
the deprotected product 5j. This was to be expected since the Boc group is stable towards 
most bases and nucleophiles, however, it is acid-labile. 
   Hexynyltrifluoroborate salt was a good coupling partner in addition to the 
previously observed phenylacetylenetrifluoroborate derivatives. Desired product 5k was 







Figure 10: Reactions of various alkynyltrifluoroborates with benzhydryl alcohols. 










3.3.3 REACTIONS OF TRANS-STYRYLTRIFLUOROBORATES 
WITH BENZHYDRYL ALCOHOLS 
 
  To our delight, we observed that potassium alkenyl trifluoroborate salts readily 
participated in the developed methodology (Figure 11). More specifically, alkenyl 
trifluoroborates such as potassium trans-styryl and 2-(3-fluorophenyl)vinyltrifluoroborate 
salts afford the desired products in good to excellent yields (6a-6e). Consistent with our 
previous findings, increasing the amount of HBF4 from 1.6 to 2.6 equivalents in the 
presence of a dimethylamine substituent translated to a yield increase of 6d from 67% to 
84%. As well, decreasing the amount of HBF4 from 1.6 to 1.3 equivalents in the presence 
of a carboxylic acid containing benzhydryl alcohol resulted in a modest yield increase of 
6e from 71% to 77%. 
 
Figure 11: Reactions of trans-styryltrifluoroborates with benzhydryl alcohols. Using 




3.3.4 UNSUCCESSFUL TRIFLUOROBORATE SALT COUPLING 
PARTNERS 
 
  When looking into the substrate scope of organotrifluoroborates, a few did not 
prove to be successful coupling partners (Figure 12). More specifically, potassium 
phenylacetylenetrifluoroborate salts that contained para-methoxy (1b) or para-butyl (1c) 
groups did not react to form the desired products. Instead, the reactions resulted in the 
consumption of the benzhydrol starting material and subsequent formation of multiple 
unidentified byproducts. This illustrates that the method is not tolerant to 
phenylacetylenetrifluoroborates containing electron donating groups. This is contrary to 
what was observed in the above substrate scope, whereby, electron withdrawing halide 
groups on the phenylacetylenetrifluoroborates proved to be successful coupling partners. 
As a result, electron-rich trifluoroborates were poor coupling partners. 
 
   
Figure 12: Organotrifluoroborates that did not participate in the developed 
methodology 
  With hopes to expand the substrate scope to aryltrifluoroborates, we attempted the 
coupling reaction with potassium phenyltrifluoroborate salt. However, these efforts were 
unproductive as multiple byproduct spots were observed on a TLC plate. Moreover, 
benzhydrol starting material was still present after leaving the reaction for several hours. 
Due to no change in the concentration of starting material estimated by TLC, potassium 
phenyltrifluoroborate salt was likely decomposed by HBF4. 
 Lastly, we observed that alkenyl trifluoroborate salts proved to be successful 




if potassium vinyltrifluoroborate salt would react to afford the desired product. However, 
similar results were observed as in the case of potassium phenyltrifluoroborate, whereby, 
multiple byproducts were formed and benzhydrol starting material was still present after 
several hours. 
 
3.3.5 APPLICATION OF THE DEVELOPED METHODOLOGY TO 
THE SYNTHESIS OF BENZOFURAN 9 
 
 To illustrate the utility of the established method, we developed a preparation of 
synthetically useful benzofurans. Annulations of ortho-propargyl phenols have been shown 
to occur in the presence of bases to form 2,3-disubstituted benzofurans[46]. We decided to 
apply this cyclization procedure to a product synthesized via our methodology. Our 
retrosynthetic analysis gave rise to a three-step approach illustrated in the following 
Scheme 27. 
 
Scheme 27: Retrosynthetic analysis towards the synthesis of benzofuran 
  Initially, we proposed that the reaction of 2-hydroxybenzaldehyde with 4-




methoxyphenyl)methyl)phenol (V). This benzhydryl alcohol could then react with 
phenylacetylenetrifluoroborate salt 1a under the developed methodology to afford ortho-
propargyl phenol (VI). After application of the known cyclization procedure[46], 
benzofuran (VII) should be obtained. 
However, issues arose when trying to conduct the first step of the synthesis 
(Scheme 28). More specifically, when the reaction was initially run with 2.0 equivalents of 
4-methoxyphenylmagnesium bromide, the 2-hydroxybenzaldehyde starting material was 
not completely consumed over the course of the reaction. However, a product spot had 
developed and was isolated after observing that the reaction was no longer progressing. 
NMR analysis showed that product had formed, however, inseparable byproducts co-eluted 
with the benzhydryl alcohol. A final attempt at the reaction resulted in the use of 3.0 
equivalents of 4-methoxyphenylmagnesium bromide with the intentions of it reacting 
completely with 2-hydroxybenzaldehyde. Although complete consumption of  
2-hydroxybenzaldehyde was observed, inseparable byproducts still contaminated the 
benzhydryl alcohol. As a result, we hypothesized that the hydroxyl group from  
2-hydroxybenzaldehyde interfered during the reaction with the Grignard reagent, thus 
resulting in the formation of byproducts. 
 
Scheme 28: Unsuccessful synthesis of 2-(hydroxy(4-methoxyphenyl)methyl)phenol 
   
  We then had to devise a new route towards the synthesis of 2,3-benzofurans. The 
2-hydroxyl group is imperative for the cyclization to occur in the final step, however, we 
envisioned that demethylation of a 2-methoxy group could be a viable alternative. As a 






Scheme 29: Application of the developed methodology to the synthesis of  
benzofuran 9 
 
Successful reaction between 2-methoxybenzaldehyde and p-tolylmagnesium 
bromide resulting in benzhydryl alcohol 3i in 79% yield. Applying the developed 
methodology to benzhydryl alcohol 3i using phenylacetylenetrifluoroborate salt 1a and 
HBF4 catalyst afforded compound 7 in 67% yield. The additional step involved the 
demethylation[45] of 7 using boron tribromide to afford ortho-propargyl phenol 8 in 73% 
yield. Applying the potassium tert-butoxide cyclization procedure by Luo and 










 4. METHODOLOGY DEVELOPMENT FOR 
THE PREPARATION OF 2-ALKENYL AND  
2-ALKYNYL TETRAHYDROFURANS 
 
4.1 SUBSTRATE SCOPE FOR THE SYNTHESIS OF  
2-ALKENYL AND 2-ALKYNYL TETRAHYDROPYRANS 
 
  Recently, our group has also shown that acetals and ketals act as suitable starting 
materials under similar Brønsted acid-catalyzed conditions[43]. This methodology has also 
been optimized for 2-methoxytetrahydropyran, a cyclic acetal substrate[49]. Previously, 
compounds 10a and 10b were successful synthesized using this method[49] (Figure 13). 
Phenylacetylenetrifluoroborate was a good coupling partner which resulted in the synthesis 
of 10a in excellent 82% yield. However, when trans-styryltrifluoroborate salt was used, 
product 10b was synthesized in poor 36% yield. 
 




  We then wanted to look into exploring other organotrifluoroborate salts, which 
were tolerant to this method. With poor results obtained from the use of an 
alkenyltrifluoroborate salt, we decided to focus on alkynyltrifluoroborates. We found that 
hexynyltrifluoroborate salt (1d) afforded 10c in excellent 84% yield which was comparable 
to when phenylacetylenetrifluoroborate was used. We then looked to pursue reactions with 
other phenylacetylenetrifluoroborate derivatives. However, these efforts only provided 
products 10d and 10e in meager 48% and 34% yields, respectively. Evidently, both 
electron-poor and electron-rich alkynyltrifluoroborates proved to be problematic towards 
the developed methodology, whereas, sterically unhindered neutral organotrifluoroborates 
(such as phenylacetylenetrifluoroborate and hexynyltrifluoroborate) were successful. 
 
4.2 TETRAHYDROFURAN VS TETRAHYDROPYRAN 
  With the substrate scope of organotrifluoroborates and 2-methoxytetrahydropyran 
looking discouraging due to only two products being synthesized in excellent yield, we 
looked to determine the rationale behind this observation. In 1992, Woods and coworkers 
proposed the six-membered oxocarbenium ring transition state model[50]. Later, in 1999, 
Woerpel and coworkers developed a general model, which explains the stereoselective 
reactions involving five-membered-ring oxocarbenium ions[51]. 
 
Figure 14: Transition state models for five- and six-membered oxocarbenium rings 
  In looking at the two transition states, it is evident that the 5-membered 
oxocarbenium ring transition state allows for easier approach of nucleophiles in terms of 
steric accessibility, as compared to the 6-membered oxocarbenium ion (Figure 14). Due to 





4.3 OPTIMIZATION REACTIONS FOR THE PREPARATION 
OF 2-ALKYNYLTETRAHYDROFURAN 11a 
  
  Initially, we looked to investigate into the efficiency of the HBF4 Brønsted acid-
catalyst towards the substitution of 2-ethoxytetrahydrofuran by using unsubstituted 
potassium phenylacetylenetrifluoroborate salt 1a as a model substrate (Table 2). 
 
Table 2: Optimization of Conditions for the Synthesis of Tetrahydrofuran 11a 
 
 
Entry BF3K (equiv.) Brønsted Acid Brønsted Acid (equiv.) Yield (%) 
1 1.1 HBF4·OEt2 1.1 75 
2 1.1 CF3COOH 1.1 trace 
3 1.5 HBF4·OEt2 1.5 92 
 
 Previously, it has been found that when using acyclic acetals, a slight excess of 1.1 
equivalents of both the organotrifluoroborate and HBF4 acid catalyst afforded the desired 
products in good to excellent yields[43]. Therefore, we began our optimization with identical 
stoichiometry (Table 2, entry 1). We found that the substitution was achieved with 75% of 
the desired product 11a. Attempts to use trifluoroacetic acid, a Brønsted acid with a similar 
pKa to that of HBF4, only resulted in trace amounts of product formation (Table 2, entry 
2). However, increasing the amount of the organotrifluoroborate and HBF4 catalyst to 1.5 
equivalents resulted in higher yields when using the six-membered ring substrate,  
2-methoxytetrahydropyran[49]. In applying these reaction conditions to 2-
ethoxytetrahydrofuran, we were able to obtain product 11a in an excellent 92% yield 
(Table 2, entry 3). Since other reaction conditions, such as reaction temperature and solvent 
were already extensively studied in our previous methodologies[42,43,49], we decided to 




4.4 PROPOSED MECHANISTIC PATHWAY 
 
  Illustrated in the following Scheme 30 is our proposed mechanistic pathway for the 
formation of 2-alkenyl and 2-alkynyl tetrahydrofurans. We propose that initial protonation 
of 2-ethoxytetrahydrofuran occurs in the presence of the Brønsted acid catalyst. 
Subsequent elimination of ethanol from compound VII results in the formation of the 5-
membered-ring oxocarbenium ion intermediate (IX). Reaction at the 2-position by 
nucleophilic organotrifluoroborate results in the generation of the desired product (X). 
With boron trifluoride being a byproduct, we propose that the in situ generation of ethanol 
is advantageous since it can act as a sequestering agent. Previously, McMillian and co-
workers had to externally add hydrofluoric acid in order to sequester the boron trifluoride 
byproduct[18]. 
 











4.5 RESULTS AND DISCUSSION 
   
  With the developed reaction conditions at hand, our next step was to look at the 
scope of organotrifluoroborate salts that are capable of participating in the reaction. 
 
4.5.1 REACTIONS OF ALKYNYLTRIFLUOROBORATE SALTS 
WITH 2-ETHOXYTETRAHYDROFURAN 
 
 Neutral naphthylacetylenetrifluoroborate salt proved to be a good coupling partner 
as product 11b was obtained in a nearly quantitative yield (Figure 15). Both electron-rich 
p-butyl and p-methoxy substituted derivatives of phenylacetylenetrifluoroborate salt 
afforded products 11c and 11d in 93% and 78% yields, respectively. Remarkably, a scale-
up reaction afforded 0.18 g of 11c in essentially identical yield to the small-scale synthesis. 
The developed methodology was also tolerant to phenylacetylenetrifluoroborate 
derivatives, which contained electron-withdrawing substituents such as dichloro, fluoro 
and trifluoromethyl. Products 11e-11g were obtained in good to excellent yields. Lastly, 












4.5.2 REACTIONS OF STYRYLTRIFLUOROBORATE SALTS WITH 
2-ETHOXYTETRAHYDROFURAN 
 
To our delight, we discovered that potassium alkenyltrifluoroborate salts also 
participated in the reaction. Namely, potassium trans-styryltrifluoroborate salts afforded 






Figure 16: Reactions of potassium trans-styryltrifluoroborate salts with  
2-ethoxytetrahydrofuran 
 
 When unsubstituted potassium trans-styryltrifluoroborate salt was used, product 
12a was obtained in 74% yield. We then looked at the effect of aromatic substituents on 
the styryltrifluoroborates. We found that potassium 2-(3-fluorophenyl)vinyltrifluoroborate  
and potassium (E)-trifluoro(4-(trifluoromethyl)styryl)borate (2a) reacted similarly to the 
unsubstituted trans-styryltrifluoroborate salt. Desired products 12b and 12c were formed 
in 78% yield. Conversely, electron-rich trans-styryltrifluoroborate salt derivative 
containing a methyl group in the para-position only resulted in a modest 54% yield of 
product 12d. Additionally, product 12e was obtained in 72% yield from reaction of  
2-ethoxytetrahydrofuran with potassium (E)-4-phenylstyryltrifluoroborate salt (2c). 
Lastly, when potassium trifluoro(1H-inden-2-yl)borate (2d) was used, product 12f was 






 5. CONCLUSIONS AND FUTURE WORK 
 
  A novel set of Brønsted acid-catalyzed reactions has been developed. At the outset, 
the preparation of internal alkenes and alkynes from benzhydryl alcohols and 
organotrifluoroborates has been shown[42]. This transformation was shown to proceed 
rapidly in the presence of a HBF4 Brønsted acid without the necessity to exclude air or 
moisture. Excellent atom economy was illustrated as organotrifluoroborates and 
benzhydryl alcohols were shown to react in a 1:1 ratio. Additionally, functional group 
tolerance superior to that of Lewis acid- and metal-catalyzed approaches was 
demonstrated. Namely, this method was tolerant to a variety of unprotected functional 
groups such as free hydroxyl, amide, aldehyde and carboxylic acid. 
 Additionally, Brønsted acid-catalyzed direct substitution of  
2-ethoxytetrahydrofuran has been demonstrated[52]. Specifically, alkenyl- and alkynylation 
of 2-ethoxytetrahydrofuran readily occurred in the presence of alkenyl- and 
alkynyltrifluoroborates and HBF4. Functionalized furans were obtained in moderate to 
excellent yields. 
 In future, further investigation into the scope of this reaction is of interest. We plan 
to look at other in situ generated carbocations that could participate in this reaction, as well 
as additional nucleophiles tolerant to this method. Furthermore, application of this method 
towards C-glycosylation of sugars is of interest. Currently, direct C-glycosylation of 
organotrifluoroborates with glycosyl fluorides is known[16]. However, this method requires 
the use of BF3·OEt2 Lewis acid. Furthermore, C-glycosylation of 5-membered ring sugars 
using alkenyltrifluoroborates was not shown. Therefore, development of a Brønsted acid-







 6. APPENDICES 
 
APPENDIX I: COMPOUND CHARACTERIZATION DATA 
 








Potassium trifluoro(phenylethynyl)borate (1a) 
The title compound was derived from phenylacetylene (2.45 
g, 24.0 mmol, 1.0 equiv), n-BuLi (1.54 g, 24.0 mmol, 1.0 
equiv), B(OMe)3 (3.75 g, 36.1 mmol, 1.5 equiv), and 
aqueous KHF2 (11.26 g, 144.2 mmol, 6.0 equiv) in 50 mL of 
THF. 1a was obtained as a white crystalline solid (1.190 g, 
24% yield). 1H NMR (DMSO) δ 7.27-7.29 (m, 4H), 7.21-
7.26 (m, 1H); 13C {1H} NMR (DMSO) δ 130.9, 128.2, 126.7, 
125.5; 19F NMR (DMSO) δ -131.71 (br. s, 3F); 11B {1H} 
NMR (DMSO) δ -1.55 (s, 1B); HRMS (ESI/M-) calcd. for 












The title compound was derived from 4-ethynylanisole 
(1.00 g, 7.34 mmol, 1.0 equiv.), n-BuLi (0.470 g, 7.34 
mmol, 1.0 equiv.), B(OMe)3 (1.14 g, 11.0 mmol, 1.5 
equiv.), and aqueous KHF2 (3.462 g, 44.3 mmol, 6.0 
equiv.) in 25 mL THF. 1b was obtained as a white 
crystalline solid (2.609 g, 55% yield). 1H NMR (DMSO) δ 
7.20-7.22 (m, 2H), 6.83-6.85 (m, 2H), 3.73 (s, 3H); 13C 
{1H} NMR (DMSO) δ 158.0, 132.2, 117.8, 113.8, 55.0; 19F 
NMR (DMSO) δ -131.50 (br. s, 3F); 11B {1H} NMR 
(DMSO) δ -1.67 (s, 1B); HRMS (ESI/M-) calcd. for 







Potassium ((4-butylphenyl)ethynyl)trifluoroborate (1c) 
The title compound was derived from 1-butyl-4-
ethynylbenzene (3.00 g, 18.0 mmol, 1.0 equiv.), n-BuLi 
(1.15 g, 18.0 mmol, 1.0 equiv.), B(OMe)3 (2.81 g, 27.0 
mmol, 1.5 equiv.), and aqueous KHF2 (8.463 g, 108 mmol, 
6.0 equiv.) in 50 mL THF. 1c was obtained as a white 
crystalline solid (2.609 g, 55% yield). 1H NMR (DMSO) δ 












Potassium trifluoro((3-chlorophenyl)ethynyl)borate (1f) 
The title compound was derived from 3-chloro-1 
ethynylbenzene (0.44 g, 3.25 mmol, 1.0 equiv), t-BuLi (0.21 
g, 3.25 mmol, 1.0 equiv), B(OMe)3 (0.51 g, 4.87 mmol, 1.5 
equiv), and aqueous KHF2 (1.52 g, 19.5 mmol, 6.0 equiv) in 
10.0 mL of THF. 1f was obtained as a white crystalline solid 
(0.460 g, 59% yield). 1H NMR (DMSO) δ 7.30-7.32 (m, 
3H), 7.24-7.28 (m, 1H); 13C {1H} NMR (DMSO) δ 132.8, 
130.3, 130.1, 129.7, 127.4, 126.9; 19F NMR (DMSO) δ           
-131.98 (br. s, 3F); 11B {1H} NMR (DMSO) δ -1.51 (s, 1B); 
2H), 1.49-1.56 (m, 2H), 1.24-1.33 (m, 2H), 0.88 (t, J = 7.4 
Hz, 3H); 13C {1H} NMR (DMSO) δ 140.9, 130.8, 128.2, 
122.8, 34.6, 32.9, 21.7, 13.8; 19F NMR (DMSO) δ -131.60 
(br. s, 3F); 11B {1H} NMR (DMSO) δ -1.67 (s, 1B); HRMS 






Potassium trifluoro(hex-1-yn-1-yl)borate (1d) 
The title compound was derived from 1-hexyne (2.0 g, 23.6 
mmol, 1.0 equiv), n-BuLi (1.51 g, 23.6 mmol, 1.0 equiv), 
B(OMe)3 (3.68 g, 35.4 mmol, 1.5 equiv), and aqueous KHF2 
(11.06 g, 142 mmol, 6.0 equiv) in 25 mL of THF. 1d was 
obtained as a white crystalline solid (1.659 g, 36% yield). 
1H NMR (DMSO) δ 1.98 (m, 2H) 1.33 (m, 4H), 0.85 (m, 
3H); 13C {1H} NMR (DMSO) δ 31.1, 21.4, 18.5, 13.5; 19F 
NMR (DMSO) δ -131.01 (br. s, 3F); 11B {1H} NMR 
(DMSO) δ -1.30 (s, 1B); HRMS (ESI/M-) calcd. for 










The title compound was derived from 3,4-dichloro-1-
ethynylbenzene (0.894 g, 5.22 mmol, 1.0 equiv), n-BuLi 
(0.335 g, 5.22 mmol, 1.0 equiv), B(OMe)3 (0.81 g, 7.84 
mmol, 1.5 equiv), and aqueous KHF2 (2.45 g, 31.3 mmol, 
6.0 equiv) in 17.5 mL of THF. 1e was obtained as an off-
white crystalline solid (0.618 g, 43% yield). 1H NMR 
(DMSO) δ 7.51-7.54 (m, 2H), 7.26 (dd, J = 2.0, 8.2 Hz, 1H); 
13C {1H} NMR (DMSO) δ 132.8, 131.7, 131.4, 130.9, 
130.0, 126.4, 109.9; 19F NMR (DMSO) δ -132.12 (br. s, 
3F); 11B {1H} NMR (DMSO) δ -1.70 (s, 1B); HRMS 















The title compound was derived from 1-ethynyl-2-
trifluoromethylbenzene (1.00 g, 5.70 mmol, 1.0 equiv), n-
BuLi (0.365 g, 5.70 mmol, 1.0 equiv), B(OMe)3 (0.89 g, 
8.55 mmol, 1.5 equiv), and aqueous KHF2 (2.67 g, 34.2 
mmol, 6.0 equiv) in 17.0 mL of THF. 1h was obtained as a 
white crystalline solid (0.879 g, 56% yield). 1H NMR 
(DMSO) δ 7.65 (d, J = 7.4 Hz, 1H), 7.51-7.58 (m, 2H), 7.39-
7.44 (m, 1H); 13C {1H} NMR (DMSO) δ 134.1, 132.0, 129.4 
(q, J = 29.1 Hz), 126.9, 125.5 (q, J = 5.4 Hz), 123.7 (q, J = 
273.0 Hz), 123.6; 19F NMR (DMSO) δ -60.85 (s, 3F), -
132.09 (br. s, 3F); 11B {1H} NMR (DMSO) δ -1.61 (s, 1B); 








The title compound was derived from 1-ethynyl-3,5-bis-
(trifluoromethyl)benzene (1.00 g, 4.07 mmol, 1.0 equiv), n-
BuLi (0.261 g, 4.07 mmol, 1.0 equiv), B(OMe)3 (0.63 g, 
6.11 mmol, 1.5 equiv), and aqueous KHF2 (1.90 g, 24.4 
mmol, 6.0 equiv) in 12.2 mL of THF. 1i was obtained as a 
white crystalline solid (0.444 g, 32% yield). 1H NMR 







Potassium trifluoro((3-fluorophenyl)ethynyl)borate (1g) 
The title compound was derived from 1-ethynyl-3-
fluorobenzene (0.67 g, 5.44 mmol, 1.0 equiv), n-BuLi 
(0.349 g, 5.44 mmol, 1.0 equiv), B(OMe)3 (0.85 g, 8.16 
mmol, 1.5 equiv), and aqueous KHF2 (2.55 g, 32.7 mmol, 
6.0 equiv) in 17.0 mL of THF. 1g was obtained as a white 
crystalline solid (1.038 g, 84% yield). 1H NMR (DMSO) δ 
7.30-7.35 (m, 1H), 7.07-7.14 (m, 3H); 13C {1H} NMR 
(DMSO) δ 161.8 (d, J = 243.1 Hz), 130.3 (d, J = 9.2 Hz), 
127.5 (d, J = 9.2 Hz), 127.3 (d, J = 3.1 Hz), 117.3 (d, J = 
22.2 Hz), 114.0 (d, J = 21.5 Hz); 19F NMR (DMSO) δ              
-113.49 (q, J = 6.6 Hz, 1F), -131.97 (br. s, 3F); 11B {1H} 
NMR (DMSO) δ -1.56 (s, 1B); HRMS (ESI/M-) calcd. for 




131.3, 130.6 (q, J = 33.0 Hz), 127.9, 123.0 (q, J = 273.0 Hz), 
120.1; 19F NMR (DMSO) δ -61.73 (s, 6F), -132.41 (br. s, 
3F); 11B {1H} NMR (DMSO) δ -1.65 (s, 1B); HRMS 








Potassium trifluoro(naphthalen-1-ylethynyl)borate (1j) 
The title compound was derived from 1-ethynylnaphthalene 
(0.854 g, 5.44 mmol, 1.0 equiv), n-BuLi (0.349 g, 5.44 
mmol, 1.0 equiv), B(OMe)3 (0.85 g, 8.16 mmol, 1.5 equiv), 
and aqueous KHF2 (2.55 g, 32.7 mmol, 6.0 equiv) in 17.0 
mL of THF. 1j was obtained as a slightly pink crystalline 
solid (0.876 g, 62% yield). 1H NMR (DMSO) δ 8.33 (d, J = 
8.2 Hz, 1H), 7.91 (d, J = 8.6 Hz, 1H), 7.82 (d, J = 8.2 Hz, 
1H), 7.51-7.61 (m, 3H), 7.42-7.45 (m, 1H); 13C {1H} NMR 
(DMSO) δ 132.9, 132.8, 128.9, 128.1, 126.9, 126.3, 126.2, 
126.1, 125.5, 123.1; 19F NMR (DMSO) δ -131.46 (br. s, 3F); 
11B {1H} NMR (DMSO) δ -1.61 (s, 1B); HRMS (ESI/M-) 












 The title compound was derived from 4-ethynylbiphenyl 
(1.00 g, 5.44 mmol, 1.0 equiv), n-BuLi (0.349 g, 5.44 mmol, 
1.0 equiv), B(OMe)3 (0.85 g, 8.16 mmol, 1.5 equiv), and 
aqueous KHF2 (2.55 g, 32.7 mmol, 6.0 equiv) in 17.0 mL of 
THF. 1k was obtained as an off-white crystalline solid 
(0.201 g, 13% yield). 1H NMR (DMSO) δ 7.65-7.67 (d, J = 
7.03 Hz, 2H), 7.58-7.61 (d, J = 8.6 Hz, 2H), 7.44-7.47 (m, 
2H), 7.33-7.39 (m, 3H); 13C {1H} NMR (DMSO) δ 139.5, 
138.3, 131.5, 128.9, 127.5, 126.48, 126.45, 124.7; 19F NMR 
(DMSO) δ -131.70 (br. s, 3F); 11B {1H} NMR (DMSO) δ -
1.22 (s, 1B); HRMS (ESI/M-) calcd. for C14H9BF3 







The title compound was derived from trans-2-[4-
(trifluoromethyl) phenyl]vinylboronic acid (0.65 g, 3 mmol, 
1.0 equiv.) and aqueous KHF2 (0.66 g, 8.4 mmol, 2.8 equiv.) 
in 6 mL Et2O. 2a was obtained as a white crystalline solid 
(0.694 g, 83% yield). 1H-NMR (DMSO) δ 7.58–7.60 (m, 




J = 3.5, 18.0 Hz, 1H); 13C {1H} NMR (DMSO) δ 144.3, 
131.8 (q, J = 4.6 Hz), 125.9, 125.2 (q, J = 3.8 Hz), 124.7 (q, 
J = 300.6 Hz); 19F NMR (DMSO) δ −60.60 (s, 3F), −138.31 






Potassium (E)-trifluoro(4-methylstyryl)borate (2b) 
The title compound was derived from trans-2-(4-
methylphenyl) vinylboronic acid (0.49 g, 3 mmol, 1.0 
equiv.) and aqueous KHF2 (0.66 g, 8.4 mmol, 2.8 equiv.) in 
6 mL Et2O. 2b was obtained as a white crystalline solid 
(0.562 g, 84% yield). 1H-NMR (DMSO) δ 7.19 (d, J = 8.2 
Hz, 2H), 7.05 (d, J = 7.8 Hz, 2H), 6.42 (d, J = 18.0 Hz, 1H), 
6.10 (dq, J = 3.5, 18.0 Hz, 1H), 2.25 (s, 3H); 13C {1H} NMR 
(DMSO) δ 137.6, 134.7, 132.8, 128.8, 125.3, 20.7; 19F NMR 







The title compound was derived from trans-2-(4-biphenyl) 
vinylboronic acid (0.67 g, 3 mmol, 1.0 equiv.) and aqueous 
KHF2 (0.66 g, 8.4 mmol, 2.8 equiv.) in 6 mL Et2O. 2c was 
obtained as a white crystalline solid (0.108 g, 13% yield). 
1H-NMR (DMSO) δ 7.63–7.66 (m, 2H), 7.55–7.58 (m, 2H), 
7.39–7.46 (m, 4H), 7.30–7.35 (m, 1H), 6.52 (d, J, = 18.0 Hz, 
1H), 6.25 (dq, J = 3.5, 18.0 Hz, 1H); 13C {1H} NMR 
(DMSO) δ 140.1, 139.5, 137.5, 132.5, 128.9, 127.0, 126.6, 





Potassium trifluoro(1H-inden-2-yl)borate (2d) 
The title compound was derived from 1H-indene-2-boronic 
acid (0.48 g, 3 mmol, 1.0 equiv.) and aqueous KHF2 (0.66 
g, 8.4 mmol, 2.8 equiv.) in 6 mL Et2O. 2d was obtained as 
an off-white crystalline solid (0.537 g, 81% yield). 1H-NMR 
(DMSO) δ 7.33–7.35 (m, 1H), 7.19–7.20 (m, 1H), 7.08–
7.12 (m, 1H), 6.94–6.98 (m, 1H), 6.55 (s, 1H), 3.16 (s, 1H); 
13C {1H} NMR (DMSO) δ 147.5, 145.7, 129.8, 125.4, 
123.1, 122.2, 119.0, 41.7; 19F NMR (DMSO) δ −137.30 (br. 


















The title compound was derived from 4-
hydroxybenzaldehyde (0.153 g, 1.25 mmol, 1.0 equiv) 
and phenylmagnesium bromide (0.453 g, 2.50 mmol, 2.0 
equiv) in 5.0 mL of anhydrous THF. Purification by 
automated flash column chromatography on silica gel 
using hexanes/EtOAc (3:1) afforded product 3a (0.196 g, 
79% yield) as a white solid. IR (Diamond-ATR) ν 3393, 
3154, 1595, 1447, 1171, 1000, 815, 695, 556 cm-1; 1H 
NMR (DMSO) δ 9.22 (s, 1H), 7.26-7.34 (m, 4H), 7.12-
7.19 (m, 3H), 6.67 (d, J = 8.6 Hz, 2H), 5.67 (d, J = 3.9 
Hz, 1H), 5.59 (d, J = 3.9 Hz, 1H); 13C {1H} NMR 
(DMSO) δ 156.1, 146.1, 136.1, 127.9, 127.5, 126.4, 











The title compound was derived from 4-
methoxybenzaldehyde (0.139 g, 1.02 mmol, 1.0 equiv) 
and 4-methoxyphenylmagnesium bromide (0.649 g, 3.07 
mmol, 3.0 equiv) in 3.0 mL of anhydrous THF. 
Purification by silica gel column chromatography using 
hexanes/EtOAc (5:1) afforded product 3b (0.248 g, 99% 
yield) as a yellow solid. IR (Diamond-ATR) ν 3287, 
1608, 1507, 1239, 1167, 1028, 809, 549 cm-1; 1H NMR 
(CDCl3) δ 7.26 (d, J = 8.2 Hz, 4H), 6.86 (d, J = 9.0 Hz, 
4H), 5.75 (s, 1H), 3.78 (s, 6H), 2.18 (s, 1H); 13C {1H} 










The title compound was derived from 4-
chlorobenzaldehyde (0.1413 g, 1.01 mmol, 1.0 equiv) 
and 4-methoxyphenylmagnesium bromide (0.850 g, 4.02 
mmol, 4.0 equiv) in 3.0 mL of anhydrous THF. 
Purification by silica gel chromatography using 
hexanes/EtOAc (5:1) afforded product 3c (0.203 g, 81% 
yield) as an off-white solid. IR (Diamond-ATR) ν 3300, 
1509, 1247, 1170, 1031, 1004, 802, 551, 516 cm-1; 1H 
NMR (CDCl3) δ 7.30 (s, 4H), 7.24 (d, J = 8.6 Hz, 2H), 
6.86 (d, J = 8.6 Hz, 2H), 5.77 (d, J = 3.1 Hz, 1H), 3.79 (s, 
3H), 2.20 (d, J = 3.5 Hz, 1H); 13C {1H} NMR (CDCl3) δ 


















The title compound was derived from 4-
(dimethylamino)benzaldehyde (0.174 g, 1.17 mmol, 1.0 
equiv) and 4-methoxyphenylmagnesium bromide (0.271 
g, 1.28 mmol, 1.1 equiv) in 3.0 mL of anhydrous THF. 
Purification by automated flash column chromatography 
on silica gel using hexanes/EtOAc (5:1) afforded product 
3d (0.174, 58% yield) as an off white solid. IR (Diamond-
ATR) ν 3299, 1612, 1510, 1244, 1169, 1031, 804, 550 
cm-1; 1H NMR (CDCl3) δ 7.29 (d, J = 8.6 Hz, 2H), 7.20 
(d, J = 8.2 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 6.69 (d, J = 
9.0 Hz, 2H), 5.73 (d, J = 3.5 Hz, 1H), 3.78 (s, 3H), 2.92 
(s, 6H), 2.07 (d, J = 3.9 Hz, 1H); 13C {1H} NMR (CDCl3) 
δ 158.7, 150.1, 136.6, 132.2, 127.64, 127.56, 113.7, 












The title compound was derived from 4-
acetamidobenzaldehyde (0.192 g, 1.18 mmol, 1.0 equiv) 
and 4-methylphenylmagnesium bromide (0.459 g, 2.35 
mmol, 2.0 equiv) in 3.0 mL of anhydrous THF. 
Purification by automated flash column chromatography 
on silica gel using hexanes/EtOAc (1:1) afforded product 
3e (0.199 g, 66% yield) as a yellow solid. Mp 139−142 
°C; IR (Diamond-ATR) ν 3309, 1657, 1601, 1535, 1412, 
1318, 1268, 1012, 819, 758, 552, 477 cm-1; 1H NMR 
(DMSO) δ 9.85 (s, 1H), 7.48 (d, J = 8.6 Hz, 2H), 7.21-
7.25 (m, 4H), 7.09 (d, J = 7.8 Hz, 2H), 5.72 (d, J = 4.3 
Hz, 1H), 5.60 (d, J = 3.9 Hz, 1H), 2.25 (s, 3H), 2.01 (s, 
1H); 13C {1H} NMR (DMSO) δ 168.0, 142.8, 140.5, 
137.8, 135.5, 128.5, 126.5, 126.1, 118.7, 73.7, 23.9, 20.6; 
HRMS (ESI-TOF) m/z [M+H]+ calcd for C16H18NO2 








The title compound was derived from 4-(Boc-
amino)benzaldehyde (0.100 g, 0.45 mmol, 1.0 
equiv) and 4-methoxyphenylmagnesium bromide 
(0.239 g, 1.13 mmol, 2.5 equiv) in 3.0 mL of 
anhydrous THF. Purification by silica gel 







afforded product 3f (0.111 g, 74% yield) as a 
yellow solid. Mp 106−109 °C; IR (Diamond-
ATR) ν 3367, 1696, 1507, 1235, 1157, 1035, 824, 
574 cm-1; 1H NMR (CDCl3) δ 7.24-7.32 (m, 6H), 
6.85 (d, J = 8.6 Hz, 2H), 6.47 (s, 1H), 5.75 (s, 1H), 
3.78 (s, 3H), 2.16 (s, 1H), 1.50 (s, 9H); 13C {1H} 
NMR (CDCl3) δ 159.0, 152.7, 138.7, 137.6, 
136.2, 127.8, 127.1, 118.5, 113.8, 80.5, 75.4, 
55.3, 28.3; HRMS (ESI-TOF) m/z [M+Na]+ calcd 















The title compound was derived from 4-formylbenzoic 
acid (0.174 g, 1.16 mmol, 1.0 equiv) and 4-
methoxyphenylmagnesium bromide (0.737 g, 3.48 
mmol, 3.0 equiv) in 5.0 mL of anhydrous THF. 
Purification by silica gel chromatography using 
hexanes/EtOAc/AcOH (1.5:1:0.01% v/v) afforded 
product 3g (0.208 g, 69% yield) as a white solid. Mp 158-
160 °C; IR (Diamond-ATR) ν 3468, 2920, 1675, 1607, 
1508, 1423, 1293, 1228, 1169, 1025, 742, 551 cm-1; 1H 
NMR (DMSO) δ 12.80 (s, 1H), 7.87 (d, J = 8.6 Hz, 2H), 
7.47 (d, J = 8.2 Hz, 2H), 7.27 (d, J = 8.6 Hz, 2H), 6.86 
(d, J = 8.6 Hz, 2H), 5.92 (s, 1H), 5.71 (s, 1H), 3.71 (s, 
3H); 13C {1H} NMR (DMSO) δ 167.2, 158.2, 150.9, 
137.2, 129.2, 129.1, 127.5, 126.1, 113.5, 73.4, 55.0; 
HRMS (ESI-TOF) m/z [M-H]- calcd for C15H13O4 














The title compound was derived from 4-
(diethoxymethyl) benzaldehyde (0.258 g, 1.24 mmol, 1.0 
equiv) and 4-methoxyphenylmagnesium bromide (0.419 
g, 1.98 mmol, 1.6 equiv) in 3.0 mL of anhydrous THF. 
Purification by silica gel chromatography using 
hexanes/EtOAc (3:1) afforded product 3h (66.0 mg, 22% 
yield) as a yellow oil. IR (Diamond-ATR) ν 3421, 1690, 
1605, 1509, 1244, 1169, 1027, 818, 785, 554 cm-1; 1H 
NMR (CDCl3) δ 9.98 (s, 1H), 7.84 (d, J = 8.6 Hz, 2H), 
7.56 (d, J = 8.2 Hz, 2H), 7.26 (d, J = 8.6 Hz, 2H), 6.87 
(d, J = 8.6 Hz, 2H), 5.86 (s, 1H), 3.79 (s, 3H), 2.34 (s, 
1H); 13C {1H} NMR (CDCl3) δ 191.9, 159.4, 150.6, 


















The title compound was derived from 2-
methoxybenzaldehyde (0.298 g, 2.19 mmol, 1.0 equiv) 
and p-tolylmagnesium bromide (0.642 g, 3.29 mmol, 1.5 
equiv) in 5.0 mL of anhydrous THF. Purification by 
automated flash column chromatography on silica gel 
using hexanes/EtOAc (gradient: 49:1 → 12:1) afforded 
product 3i (0.396 g, 79% yield) as a white solid. IR 
(Diamond-ATR) ν 3298, 1598, 1486, 1280, 1240, 1186, 
1029, 806, 749, 556 cm-1; 1H NMR (CDCl3) δ 7.26-7.20 
(m, 4H), 7.10 (d, J = 7.8 Hz, 2H), 6.92 (t of d, J = 0.8, 7.4 
Hz, 1H), 6.85 (d of d, J = 0.8, 8.6 Hz, 1H), 6.00 (s, 1H), 
3.76 (s, 3H), 3.05 (s, 1H), 2.31 (s, 3H); 13C {1H} NMR 
(CDCl3) δ 156.6, 140.3, 136.6, 132.1, 128.8, 128.5, 



























The title compound was derived from diphenylmethanol 
(13.3 mg, 0.072 mmol, 1.0 equiv), potassium 
trifluoro(phenylethynyl)borate (1a) (15.0 mg, 0.072 mmol, 
1.0 equiv), and HBF4·OEt2 (18.7 mg, 0.12 mmol, 1.6 equiv) 
in 0.3 mL of CH3CN. Purification by automated flash 
column chromatography on silica gel using hexanes and 
subsequent CH3CN/ hexanes extraction afforded product 4a 
(7.8 mg, 41% yield) as a yellow oil. IR (Diamond-ATR) ν 
2922, 1595, 1488, 1451, 755, 689, 558 cm-1; 1H NMR 
(CDCl3) δ 7.43-7.49 (m, 6H), 7.29-7.34 (m, 7H), 7.21-7.25 
(m, 2H), 5.21 (s, 1H); 13C {1H} NMR (CDCl3) δ 141.7, 










The title compound was derived from phenyl(p-
tolyl)methanol (21.1 mg, 0.11 mmol, 1.0 equiv), potassium 
trifluoro(phenylethynyl)borate (1a) (22.1 mg, 0.11 mmol, 
1.0 equiv), and HBF4·OEt2 (27.5 mg, 0.17 mmol, 1.6 equiv) 
in 0.3 mL of CH3CN. Purification by silica gel column 
chromatography using hexanes afforded product 4b (20.2 
mg, 67% yield) as a yellow oil. IR (Diamond-ATR) ν 2921, 
1654, 1602, 1490, 1448, 1275, 1176, 695 cm-1; 1H NMR 
(CDCl3) δ 7.42-7.48 (m, 4H), 7.28-7.33 (m, 7H), 7.20-7.24 
(m, 1H), 7.13 (d, J = 7.8 Hz, 2H), 5.17 (s, 1H), 2.31 (s, 3H); 
13C {1H} NMR (CDCl3) δ 141.9, 138.8, 136.5, 131.7, 129.3, 
128.6, 128.2, 127.9, 127.83, 127.75, 126.8, 123.6, 90.4, 








The title compound was derived from phenyl(o-
tolyl)methanol (21.1 mg, 0.11 mmol, 1.0 equiv), potassium 
trifluoro(phenylethynyl)borate (1a) (22.1 mg, 0.11 mmol, 
1.0 equiv), and HBF4·OEt2 (27.5 mg, 0.17 mmol, 1.6 equiv) 
in 0.3 mL of CH3CN. Purification by silica gel column 
chromatography using hexanes afforded product 4c (15.2 
mg, 51% yield) as a yellow oil. IR (Diamond-ATR) ν 2923, 
1597, 1489, 1449, 1266, 1027, 754, 690 cm-1; 1H NMR 
(CDCl3) δ 7.50 (dd, J = 1.6, 7.03 Hz, 1H), 7.44-7.46 (m, 
2H), 7.37-7.39 (m, 2H), 7.27-7.32 (m, 5H), 7.14-7.25 (m, 




 140.7, 139.4, 135.9, 131.6, 130.7, 128.8, 128.5, 128.2, 











The title compound was derived from (4-methoxyphenyl) 
(phenyl)methanol (21.5 mg, 0.10 mmol, 1.0 equiv), 
potassium trifluoro(phenylethynyl)borate (1a) (20.9 mg, 
0.10 mmol, 1.0 equiv), and HBF4·OEt2 (26.0 mg, 0.16 
mmol, 1.6 equiv) in 0.3 mL of CH3CN. Purification by silica 
gel column chromatography using hexanes/diethyl ether 
(40:1) afforded product 4d (26.2 mg, 87% yield) as a yellow 
oil. IR (Diamond-ATR) ν 2930, 1598, 1507, 1247, 1173, 
1029, 755, 691 cm-1; 1H NMR (CDCl3) δ 7.41-7.48 (m, 4H), 
7.28-7.36 (m, 7H), 7.20-7.24 (m, 1H), 6.85 (d, J = 9.0 Hz, 
2H), 5.16 (s, 1H), 3.77 (s, 3H); 13C {1H} NMR (CDCl3) δ 
158.5, 142.0, 133.9, 131.7, 128.9, 128.6, 128.2, 127.9, 










The title compound was derived from bis(4-
methoxyphenyl)methanol (3b) (22.3 mg, 0.091 mmol, 1.0 
equiv), potassium trifluoro(phenylethynyl)borate (1a) (19.0 
mg, 0.091 mmol, 1.0 equiv), and HBF4·OEt2 (23.7 mg, 0.14 
mmol, 1.6 equiv) in 0.3 mL of CH3CN. Aqueous workup 
afforded product 4e (27.2 mg, 91% yield) as a yellow/orange 
oil. IR (Diamond-ATR) ν 2930, 1601, 1506, 1244, 1170, 
1027, 756, 689 cm-1; 1H NMR (CDCl3) δ 7.48-7.51 (m, 2H), 
7.36 (d, J = 8.2 Hz, 4H), 7.31-7.33 (m, 3H), 6.88 (d, J = 8.6 
Hz, 4H), 5.15 (s, 1H), 3.81 (s, 6H); 13C {1H} NMR (CDCl3) 
δ 158.4, 134.3, 131.6, 128.8, 128.2, 127.9, 123.6, 113.9, 





The title compound was derived from (4-
chlorophenyl)(phenyl)methanol (21.7 mg, 0.10 mmol, 1.0 
equiv), potassium trifluoro(phenylethynyl)- borate (1a) 
(20.6 mg, 0.10 mmol, 1.0 equiv), and HBF4·OEt2 (25.7 mg, 
0.16 mmol, 1.6 equiv) in 0.3 mL of CH3CN. Purification by 
automated flash column chromatography on silica gel using 
hexanes and subsequent CH3CN/hexanes extraction 






(Diamond-ATR) ν 2924, 1487, 1089, 1014, 753, 690, 555 
cm-1; 1H NMR (CDCl3) δ 7.46-7.48 (m, 2H), 7.35-7.42 (m, 
5H), 7.29-7.33 (m, 6H), 7.24-7.27 (m, 1H), 5.18 (s, 1H); 13C 
{1H} NMR (CDCl3) δ 141.2, 140.3, 132.7, 131.7, 129.3, 










The title compound was derived from (4-chlorophenyl)(4-
methoxyphenyl)methanol (3c) (22.4 mg, 0.090 mmol, 1.0 
equiv), potassium trifluoro(phenylethynyl)borate (1a) (18.7 
mg, 0.090 mmol, 1.0 equiv), and HBF4·OEt2 (23.4 mg, 0.14 
mmol, 1.6 equiv) in 0.3 mL of CH3CN. Purification by silica 
gel column chromatography using hexanes/EtOAc (10:1) 
afforded product 4g (25.3 mg, 84% yield) as a yellow oil. IR 
(Diamond-ATR) ν 2928, 1599, 1508, 1487, 1248, 1172, 
1089, 1014, 755, 690, 555 cm-1; 1H NMR (CDCl3) δ 7.45-
7.47 (m, 2H), 7.27-7.36 (m, 9H), 6.86 (d, J = 8.6 Hz, 2H), 
5.13 (s, 1H), 3.78 (s, 3H); 13C {1H} NMR (CDCl3) δ 158.6, 
140.6, 133.4, 132.6, 131.7, 129.2, 128.8, 128.7, 128.2, 










The title compound was derived from 4-
(hydroxy(phenyl)methyl)phenol (3a) (21.1 mg, 0.11 mmol, 
1.0 equiv), potassium trifluoro(phenylethynyl)borate (1a) 
(21.9 mg, 0.11 mmol, 1.0 equiv), and HBF4·OEt2 (27.3 mg, 
0.17 mmol, 1.6 equiv) in 0.3 mL of CH3CN. Purification was 
conducted by automated flash column chromatography on 
silica gel using hexanes/EtOAc (5:1) and subsequent 
CH3CN/hexanes extraction afforded product 4h (19.9 mg, 
66% yield) as a burgundy/brown oil. IR (Diamond-ATR) ν 
3317, 3025, 1596, 1509, 1489, 1441, 1169, 754, 690, 552 
cm-1; 1H NMR (CDCl3) 7.41-7.48 (m, 4H), 7.28-7.33 (m, 
7H), 7.22-7.24 (m, 1H), 6.77-6.79 (m, 2H), 5.14 (s, 1H); 13C 
{1H} NMR (CDCl3) δ 154.4, 142.0, 134.1, 131.7, 129.1, 


















The title compound was derived from N-(4-hydroxy(p-
tolyl)methyl)phenyl)acetamide (3e) (22.6 mg, 0.088 mmol, 
1.0 equiv), potassium trifluoro(phenylethynyl)borate (1a) 
(18.4 mg, 0.088 mmol, 1.0 equiv), and HBF4·OEt2 (22.9 mg, 
0.141 mmol, 1.6 equiv) in 0.3 mL of CH3CN. Purification 
was conducted by silica gel column chromatography using 
hexanes/EtOAc (1:2) and subsequent CH3CN/hexanes 
extraction afforded product 4i (18.3 mg, 61% yield) as a 
yellow oil. IR (Diamond-ATR) ν 3301, 2922, 1662, 1599, 
1508, 1407, 1314, 754, 689 cm-1; 1H NMR (CDCl3) 7.45-
7.49 (m, 4H), 7.38-7.40 (m, 3H), 7.30-7.33 (m, 4H), 7.14 (d, 
J = 7.8 Hz, 2H), 5.15 (s, 1H), 2.34 (s, 3H), 2.15 (s, 3H); 13C 
{1H} NMR (CDCl3) δ 168.3, 138.7, 137.9, 136.6, 136.5, 
131.6, 129.3, 128.4, 128.2, 127.9, 127.7, 123.5, 120.1, 90.3, 
84.7, 42.8, 24.5, 21.0; HRMS (ESI-TOF) m/z [M+H]+ calcd 












benzoic acid (4j) 
The title compound was derived from 4-(hydroxy(4-
methoxyphenyl)methyl)benzoic acid (3g) (13.8 mg, 0.053 
mmol, 1.0 equiv), potassium trifluoro(phenylethynyl)-
borate (1a) (11.1 mg, 0.053 mmol, 1.0 equiv), and 
HBF4·OEt2 (11.2 mg, 0.069 mmol, 1.3 equiv) in 0.3 mL of 
CH3CN. Purification was conducted by silica gel column 
chromatography using hexanes/ EtOAc/AcOH (2:1:0.01% 
v/v) and subsequent CH3CN/hexanes extraction afforded 
product 4j (11.3 mg, 62% yield) as a yellow oil. IR 
(Diamond-ATR) ν 2919, 1691, 1607, 1508, 1297, 1246, 
1173, 758, 740, 691, 554 cm-1; 1H NMR (acetone-d6) 8.02 
(d, J = 8.2 Hz, 2H), 7.63 (d, J = 8.2 Hz, 2H), 7.50 7.53 (m, 
2H), 7.44 (d, J = 8.6 Hz, 2H), 7.37-7.38 (m, 3H), 6.92 (d, 
J = 8.6 Hz, 2H), 5.41 (s, 1H), 3.77 (s, 3H); 13C {1H} NMR 
(acetone-d6) δ 159.9, 148.3, 134.5, 132.5, 131.0, 129.8, 
129.4, 129.2, 128.7, 124.3, 115.0, 91.0, 85.8, 55.6, 43.3 
(the carbonyl carbon and one aromatic carbon were not 
resolved in this spectrum); HRMS (ESI-TOF) m/z [M-H]- 

















The title compound was derived from (4-methoxyphenyl) 
(phenyl)methanol (17.6 mg, 0.082 mmol, 1.0 equiv), 
potassium trifluoro((2-(trifluoromethyl)phenyl)ethynyl)-
borate (1h) (22.6 mg, 0.082 mmol, 1.0 equiv), and 
HBF4·OEt2 (21.2 mg, 0.13 mmol, 1.6 equiv) in 0.3 mL of 
CH3CN. Purification by silica gel column chromatography 
using hexanes/EtOAc (15:1) afforded product 5a (26.8 mg, 
89% yield) as a yellow/orange oil. IR (Diamond-ATR) ν 
2929, 1601, 1508, 1314, 1249, 1167, 1127, 1031, 764, 697 
cm-1; 1H NMR (CDCl3) δ 7.64 (d, J = 7.4 Hz, 1H), 7.58 (d, 
J = 7.4 Hz, 1H), 7.42-7.47 (m, 3H), 7.30−7.38 (m, 5H), 7.21-
7.24 (m, 1H), 6.85 (d, J = 8.6 Hz, 2H), 5.20 (s, 1H), 3.77 (s, 
3H); 13C {1H} NMR (CDCl3) δ 158.5, 141.6, 134.1, 133.5, 
131.6, 131.3, 128.9, 128.6, 127.8, 127.6, 126.9, 125.7 (q, J 
= 5.4 Hz), 123.6 (q, J = 273.7 Hz), 121.8, 114.0, 96.4, 80.7, 
55.2, 43.2; 19F NMR (CDCl3) δ −62.17 (s, 3F); HRMS (EI) 











The title compound was derived from (4-methoxyphenyl) 
(phenyl)methanol (14.8 mg, 0.069 mmol, 1.0 equiv), 
potassium trifluoro((3,5-bis(trifluoromethyl)phenyl)-
ethynyl)borate (1i) (23.8 mg, 0.069 mmol, 1.0 equiv), and 
HBF4·OEt2 (17.9 mg, 0.11 mmol, 1.6 equiv) in 0.3 mL of 
CH3CN. Purification by silica gel column chromatography 
using hexanes/EtOAc (14:1) afforded product 5b (25.6 mg, 
85% yield) as a yellow/orange oil. IR (Diamond-ATR) ν 
2928, 1600, 1509, 1381, 1275, 1171, 1129, 697, 681 cm-1; 
1H NMR (CDCl3) δ 7.88 (s, 2H), 7.78 (s, 1H), 7.25-7.41 (m, 
7H), 6.88 (d, J = 9.0, 2H), 5.20 (s, 1H), 3.79 (s, 3H); 13C 
{1H} NMR (CDCl3) δ 158.8, 141.1, 132.9, 131.8 (q, J = 33.7 
Hz), 131.6 (q, J = 4.6 Hz), 128.9, 128.8, 127.8, 127.2, 125.8, 
123.0 (q, J = 273.0 Hz), 121.3 (q, J = 3.8 Hz), 114.2, 94.5, 
81.8, 55.3, 42.9; 19F NMR (CDCl3) δ -63.13 (s, 6F); HRMS 

















The title compound was derived from (4-methoxyphenyl) 
(phenyl)methanol (19.3 mg, 0.090 mmol, 1.0 equiv), 
potassium trifluoro((3-chlorophenyl)ethynyl)borate (1f) 
(21.9 mg, 0.090 mmol, 1.0 equiv), and HBF4·OEt2 (23.4 mg, 
0.14 mmol, 1.6 equiv) in 0.3 mL of CH3CN. Purification by 
silica gel column chromatography using hexanes/EtOAc 
(14:1) afforded product 5c (29.7 mg, 99% yield) as a 
yellow/orange oil. IR (Diamond-ATR) ν 2930, 1592, 1507, 
1247, 1173, 1030, 780, 696, 680 cm-1; 1H NMR (CDCl3) δ 
7.45-7.46 (m, 1H), 7.39-7.41 (m, 2H), 7.30-7.35 (m, 5H), 
7.19-7.28 (m, 3H), 6.86 (d, J = 9.0 Hz, 2H), 5.16 (s, 1H), 
3.77 (s, 3H); 13C {1H} NMR (CDCl3) δ 158.6, 141.7, 134.0, 
133.5, 131.6, 129.8, 129.4, 128.9, 128.6, 128.2, 127.8, 
126.9, 125.2, 114.0, 91.9, 83.3, 55.3, 42.9; HRMS (EI) m/z 










The title compound was derived from (4-chlorophenyl)(4-
methoxyphenyl)methanol (3c) (18.6 mg, 0.075 mmol, 1.0 
equiv), potassium trifluoro((3,4-dichlorophenyl)ethynyl)-
borate (1e) (20.7 mg, 0.075 mmol, 1.0 equiv), and 
HBF4·OEt2 (19.3 mg, 0.12 mmol, 1.6 equiv) in 0.3 mL of 
CH3CN. Purification by silica gel column chromatography 
using hexanes/EtOAc (20:1) afforded product 5d (25.0 mg, 
83% yield) as a yellow oil. IR (Diamond-ATR) ν 2926, 
1508, 1487, 1461, 1173, 1089, 1031, 817 cm-1; 1H NMR 
(CDCl3) δ 7.54 (d, J = 2.0 Hz, 1H), 7.35-7.37 (m, 1H), 
7.25−7.33 (m, 7H), 6.87 (d, J = 9.0 Hz, 2H), 5.12 (s, 1H), 
3.79 (s, 3H); 13C {1H} NMR (CDCl3) δ 158.8, 140.0, 133.3, 
132.9, 132.8, 132.48, 132.45, 130.8, 130.3, 129.1, 128.80, 
128.79, 123.2, 114.2, 92.1, 82.8, 55.3, 42.3; HRMS (EI) m/z 



















The title compound was derived from 4-(hydroxy(4-
methoxyphenyl)methyl)benzaldehyde (3h) (21.1 mg, 
0.087 mmol, 1.0 equiv), potassium trifluoro((3-
fluorophenyl)-ethynyl)borate (1g) (19.7 mg, 0.087 mmol, 
1.0 equiv), and HBF4·OEt2 (22.6 mg, 0.14 mmol, 1.6 
equiv) in 0.3 mL of CH3CN. Purification by silica gel 
column chromatography using hexanes/EtOAc (6:1) 
afforded product 5e (24.6 mg, 82% yield) as a yellow oil. 
IR (Diamond-ATR) ν 2926, 1697, 1603, 1578, 1508, 1246, 
1148, 1032, 783, 681 cm-1; 1H NMR (CDCl3) δ 9.99 (s, 
1H), 7.84 (d, J = 8.2 Hz, 2H), 7.58 (d, J = 8.2 Hz, 2H), 7.32 
(d, J = 8.6 Hz, 2H), 7.25-7.28 (m, 2H), 7.15-7.18 (m, 1H), 
7.00−7.05 (m, 1H), 6.88 (d, J = 9.0 Hz, 2H), 5.23 (s, 1H), 
3.79 (s, 3H); 13C {1H} NMR (CDCl3) δ 191.7, 162.3 (d, J 
= 246.14 Hz), 158.9, 148.5, 135.2, 132.4, 130.1, 129.8 (d, 
J = 6.2 Hz), 128.9, 128.4, 127.5 (d, J = 3.1 Hz), 124.9, 
118.5 (d, J = 23.0 Hz), 115.6 (d, J = 21.5 Hz), 114.3, 90.3, 
84.3, 55.3, 43.0; 19F NMR (CDCl3) δ -112.97 (s, 1F); 












The title compound was derived from 4-
(hydroxy(phenyl)methyl)phenol (3a) (16.7 mg, 0.083 
mmol, 1.0 equiv), potassium trifluoro([1,1’-biphenyl]-4-
ylethynyl)borate (1k) (23.6 mg, 0.083 mmol, 1.0 equiv), and 
HBF4·OEt2 (21.6 mg, 0.13 mmol, 1.6 equiv) in 0.3 mL of 
CH3CN. Purification by automated flash column 
chromatography on silica gel using hexanes/EtOAc (5:1) 
afforded product 5f (21.3 mg, 71% yield) as an orange/pink 
oil. IR (Diamond-ATR) ν 3331, 2922, 1597, 1508, 1485, 
1447, 1170, 840, 761, 692, 560 cm-1; 1H NMR (CDCl3) δ 
7.57-7.59 (m, 2H), 7.53 (s, 4H), 7.41-7.45 (m, 4H), 7.29-
7.36 (m, 5H), 7.21-7.25 (m, 1H), 6.78 (d, J = 8.6 Hz, 2H), 
5.17 (s, 1H), 4.84 (s, 1H); 13C {1H} NMR (CDCl3) δ 154.4, 
142.0, 140.7, 140.4, 134.1, 132.1, 129.1, 128.8, 128.6, 
127.8, 127.5, 127.0, 126.9, 126.8, 122.4, 115.4, 91.1, 84.6, 

















The title compound was derived from (4-methoxyphenyl) 
(phenyl)methanol (18.5 mg, 0.086 mmol, 1.0 equiv), 
potassium trifluoro(naphthalen-1-ylethynyl)borate (1j) 
(22.2 mg, 0.086 mmol, 1.0 equiv), and HBF4·OEt2 (22.3 mg, 
0.14 mmol, 1.6 equiv) in 0.3 mL of CH3CN. Purification by 
automated flash column chromatography on silica gel using 
hexanes/EtOAc (20:1) afforded product 5g (21.0 mg, 70% 
yield) as a yellow oil. IR (Diamond-ATR) ν 2926, 1603, 
1507, 1246, 1174, 1030, 797, 772, 696, 564 cm-1; 1H NMR 
(CDCl3) δ 8.33 (d, J = 7.42, Hz, 1H), 7.78-7.84 (m, 2H), 
7.70 (d, J = 7.4 Hz, 1H), 7.47-7.54 (m, 4H), 7.33-7.44 (m, 
5H), 7.23-7.27 (m, 1H), 6.88 (d, J = 8.6 Hz, 2H), 5.33 (s, 
1H), 3.78 (s, 3H); 13C {1H} NMR (CDCl3) δ 158.6, 142.1, 
134.0, 133.5, 133.2, 130.4, 129.0, 128.7, 128.4, 128.2, 
127.9, 126.9, 126.7, 126.3, 125.2, 121.2, 114.1, 95.5, 82.9, 
55.3, 43.3 (one aromatic carbon was not resolved in this 
spectrum); HRMS (EI) m/z [M+] calcd for C26H20O 










1-yl)-benzoic acid (5h) 
The title compound was derived from 4-(hydroxy(4-
methoxyphenyl)methyl)benzoic acid (3g) (19.7 mg, 0.076 
mmol, 1.0 equiv), potassium trifluoro(naphthalen-1-
ylethynyl)borate (1j) (19.7 mg, 0.076 mmol, 1.0 equiv), 
and HBF4·OEt2 (19.8 mg, 0.12 mmol, 1.6 equiv) in 0.3 mL 
of CH3CN. Purification by silica gel column 
chromatography using hexanes/EtOAc/AcOH 
(1.5:1:0.01% v/v) afforded product 5h (19.8 mg, 66% 
yield) as a yellow oil. IR (Diamond-ATR) ν 2922, 1689, 
1606, 1507, 1245, 1174, 1032, 771 cm-1; 1H NMR 
(acetone-d6) δ 8.33-8.36 (m, 1H), 8.06 (d, J = 8.2 Hz, 2H), 
7.93-7.97 (m, 2H), 7.72-7.78 (m, 3H), 7.49-7.62 (m, 5H), 
6.96 (d, J = 8.6 Hz, 2H), 5.61 (s, 1H), 3.79 (s, 3H); 13C 
{1H} NMR (acetone-d6) δ 159.9, 148.3, 134.5, 134.4, 
134.3, 131.4, 131.1, 129.9, 129.6, 129.4, 128.8, 127.9, 
127.5, 126.8, 126.4, 121.8, 115.1, 96.2, 83.8, 55.6, 43.7 
(the carbonyl carbon and one aromatic carbon were not 
resolved in this spectrum); HRMS (EI) m/z [M+] for 
















The title compound was derived from (4-
(dimethylamino)phenyl)(4-methoxyphenyl)methanol (3d) 
(20.5 mg, 0.080 mmol, 1.0 equiv), potassium trifluoro((3-
chlorophenyl)ethynyl)borate (1f) (19.4 mg, 0.080 mmol, 1.0 
equiv), and HBF4·OEt2 (33.6 mg, 0.21 mmol, 2.6 equiv) in 
0.3 mL of CH3CN. Purification by automated flash column 
chromatography on silica gel using hexanes/EtOAc (3:1) 
afforded product 5i (18.4 mg, 61% yield) as a brown oil. IR 
(Diamond-ATR) ν 2926, 1607, 1507, 1246, 1172, 1033, 
782, 680, 555 cm-1; 1H NMR (CDCl3) δ 7.44−7.45 (m, 1H), 
7.31−7.33 (m, 3H), 7.18-7.26 (m, 4H), 6.85 (d, J = 8.6 Hz, 
2h), 6.69 (d, J = 9.0 Hz, 2H), 5.08 (s, 1H), 3.78 (s, 3H), 2.91 
(s, 6H); 13C {1H} NMR (CDCl3) δ 158.4, 149.6, 134.3, 
134.0, 131.5, 129.8, 129.6, 129.4, 128.8, 128.4, 128.0, 
125.5, 113.9, 112.7, 92.7, 82.8, 55.3, 41.9, 40.6; HRMS 













The title compound was derived from tert-butyl (4-
(hydroxy(p-tolyl)methyl)phenyl)carbamate (3f) (20.5 mg, 
0.062 mmol, 1.0 equiv), potassium trifluoro((3,4-
dichlorophenyl)ethynyl)borate (1e) (17.3 mg, 0.062 mmol, 
1.0 equiv), and HBF4·OEt2 (26.2 mg, 0.16 mmol, 2.6 equiv) 
in 0.3 mL of CH3CN. Purification was conducted by silica 
gel column chromatography using hexanes/EtOAc (1.3:1) 
followed by a pentane wash and subsequent 
CH3CN/hexanes extraction to afford product 5j (15.3 mg, 
51% yield) as a burgundy oil. IR (Diamond-ATR) ν 3372, 
2928, 1607, 1506, 1461, 1244, 1173, 1127, 1030, 817, 729, 
569 cm-1; 1H NMR (CDCl3) δ 7.53 (m, 1H), 7.34−7.36 (m, 
1H), 7.24−7.30 (m, 3H), 7.15 (d, J = 8.2 Hz, 2H), 6.85 (d, J 
= 8.6 Hz, 2H), 6.64 (d, J = 8.2 Hz, 2H), 5.05 (s, 1H), 3.78 
(s, 3H); 13C {1H} NMR (CDCl3) δ 158.5, 145.3, 133.9, 
133.3, 132.3, 132.1, 131.5, 130.8, 130.2, 128.7, 128.6, 
123.7, 115.3, 114.0, 93.3, 82.0, 55.3, 42.0; HRMS (ESI-















The title compound was derived from (4-
methoxyphenyl)(phenyl)methanol (23.1 mg, 0.11 mmol, 1.0 
equiv), potassium trifluoro(hex-1-yn-1-yl)borate (1d) (20.3 
mg, 0.11 mmol, 1.0 equiv), and HBF4·OEt2 (27.9 mg, 0.17 
mmol, 1.6 equiv) in 0.3 mL of CH3CN. Purification by silica 
gel column chromatography using hexanes/EtOAc (15:1) 
afforded product 5k (21.9 mg, 73% yield) as a yellow oil. IR 
(Diamond-ATR) ν 2929, 1653, 1598, 1508, 1248, 1172, 
1029, 698 cm-1; 1H NMR (CDCl3) δ 7.34-7.36 (m, 2H), 7.26-
7.30 (m, 4H), 7.17-7.21 (m, 1H), 6.82 (d, J = 9.0 Hz, 2H), 
4.92 (s, 1H), 3.76 (s, 3H), 2.28 (td, J = 2.4, 7.0 Hz, 2H), 
1.51-1.56 (m, 2H), 1.41−1.46 (m, 2H), 0.92 (t, J = 7.0 Hz, 
3H); 13C {1H} NMR (CDCl3) δ 158.3, 142.8, 134.7, 128.8, 













The title compound was derived from (4-
methoxyphenyl)(phenyl)methanol (21.4 mg, 0.100 mmol, 
1.0 equiv), potassium trifluoro(E)-2-phenylethenylborate 
(21.0 mg, 0.100 mmol, 1.0 equiv), and HBF4·OEt2 (25.9 mg, 
0.16 mmol, 1.6 equiv) in 0.3 mL of CH3CN. Purification by 
silica gel column chromatography using hexanes/EtOAc 
(15:1) afforded product 6a (29.0 mg, 97% yield) as a pale 
yellow oil. IR (Diamond-ATR) ν 2927, 1607, 1508, 1244, 
1175, 1031, 966, 829, 744, 693, 549 cm-1; 1H NMR (CDCl3) 
δ 7.35−7.37 (m, 2H), 7.19−7.32 (m, 8H), 7.14 (d, J = 8.6 Hz, 
2H), 6.85 (d, J = 9.0 Hz, 2H), 6.65 (dd, J = 7.4, 15.6 Hz, 
1H), 6.32 (d, J = 15.6 Hz, 1H), 4.84 (d, J = 7.4 Hz, 1H), 3.77 
(s, 3H); 13C {1H} NMR (CDCl3) δ 158.1, 143.8, 137.3, 
135.6, 132.9, 131.1, 129.6, 128.6, 128.5, 128.4, 127.2, 







The title compound was derived from bis(4-
methoxyphenyl)methanol (3b) (21.0 mg, 0.086 mmol, 1.0 
equiv), potassium trifluoro(2-(3-fluorophenyl)vinyl)borate 
(19.6 mg, 0.086 mmol, 1.0 equiv), and HBF4·OEt2 (22.3 mg, 
0.14 mmol, 1.6 equiv) in 0.3 mL of CH3CN. Purification by 
silica gel column chromatography using hexanes/EtOAc 
(9:1) afforded product 6b (29.1 mg, 97% yield) as a pink oil. 




 1033, 964, 825, 553 cm-1; 1H NMR (CDCl3) δ 7.20−7.25 
(m, 1H), 7.05−7.13 (m, 6H), 6.84−6.91 (m, 5H), 6.61−6.66 
(m, 1H), 6.26 (d, J = 15.6 Hz, 1H), 4.79 (d, J = 7.4 Hz, 1H), 
3.78 (s, 6H); 13C {1H} NMR (CDCl3) δ 163.1 (d, J = 245.4 
Hz), 158.2, 139.7 (d, J = 7.7 Hz), 135.6, 134.7, 129.9 (d, J 
= 3.1 Hz), 129.8 (d, J = 2.3 Hz), 129.5, 122.1 (d, J = 2.3 Hz), 
113.94 (d, J = 21.5 Hz), 113.87, 112.7 (d, J = 22.2 Hz), 55.2, 
52.4; 19F NMR (CDCl3) δ −113.70 (q, J = 9.3 Hz, 1F); 












The title compound was derived from N-(4-hydroxy(p-
tolyl)methyl)phenyl)acetamide (3e) (22.4 mg, 0.088 mmol, 
1.0 equiv), potassium trifluoro(E)-2-phenylethenylborate 
(18.5 mg, 0.088 mmol, 1.0 equiv), and HBF4·OEt2 (22.8 mg, 
0.14 mmol, 1.6 equiv) in 0.3 mL of CH3CN. Purification was 
conducted by silica gel column chromatography using 
hexanes/EtOAc (1:2) and subsequent CH3CN/hexanes 
extraction afforded product 6c (23.2 mg, 77% yield) as a 
pale white/yellow oil. IR (Diamond-ATR) ν 3294, 2922, 
1662, 1599, 1509, 1407, 1369, 1315, 1262, 966, 816, 741, 
691, 522 cm-1; 1H NMR (CDCl3) δ 7.41−7.43 (m, 2H), 
7.34−7.37 (m, 2H), 7.15−7.29 (m, 5H), 7.10 (s, 4H), 6.61 
(dd, J = 7.4, 16.0 Hz, 1H), 6.31 (d, J = 15.6 Hz, 1H), 4.81 
(d, J = 7.4 Hz, 1H), 2.32 (s, 3H), 2.13 (s, 3H); 13C {1H} NMR 
(CDCl3) δ 168.3, 140.4, 139.7, 137.2, 136.2, 136.0, 132.6, 
131.2, 129.2, 129.1, 128.5, 128.4, 127.2, 126.3, 120.0, 53.2, 
24.5, 21.0; HRMS (ESI-TOF) m/z [M+H]+ calcd for 









The title compound was derived from (4-
(dimethylamino)phenyl)(4-methoxyphenyl)methanol (3d) 
(21.4 mg, 0.083 mmol, 1.0 equiv), potassium trifluoro(2-(3-
fluorophenyl)vinyl) borate (18.9 mg, 0.083 mmol, 1.0 
equiv), and HBF4·OEt2 (34.9 mg, 0.2 mmol, 2.6 equiv) in 
0.3 mL of CH3CN. Purification by silica gel column 
chromatography using hexanes/EtOAc (6:1) afforded 
product 6d (25.1 mg, 84% yield) as a pale white/yellow oil. 
IR (Diamond-ATR) ν 2926, 1609, 1507, 1244, 1174, 1140, 




 1H), 7.04−7.15 (m, 6H), 6.83−6.90 (m, 3H), 6.62−6.71 (m, 
3H), 6.27 (d, J = 16.0 Hz, 1H), 4.75 (d, J = 7.4 Hz, 1H), 3.78 
(s, 3H), 2.91 (s, 6H); 13C {1H} NMR (CDCl3) δ 163.1 (d, J 
= 244.6 Hz), 158.1, 149.3, 140.0 (d, J = 7.7 Hz), 136.0, 
135.1, 131.4, 129.9, 129.8, 129.5, 129.1, 122.1 (d, J = 3.1 
Hz), 113.79, 113.78 (d, J = 21.5 Hz), 112.74, 112.65 (d, J = 
22.2 Hz), 55.2, 52.3, 40.7; 19F NMR (CDCl3) δ −113.82 (q, 
J = 9.3 Hz, 1F); HRMS (ESI-TOF) m/z [M+H]+ calcd for 












benzoic acid (6e) 
The title compound was derived from 4-(hydroxy(4-
methoxyphenyl)methyl)benzoic acid (3g) (21.4 mg, 0.083 
mmol, 1.0 equiv), potassium trifluoro(2-(3-
fluorophenyl)vinyl) borate (18.9 mg, 0.083 mmol, 1.0 
equiv), and HBF4·OEt2 (17.4 mg, 0.12 mmol, 1.3 equiv) in 
0.3 mL of CH3CN. Purification was conducted by silica gel 
column chromatography using hexanes/EtOAc/AcOH 
(2:1:0.01% v/v) and subsequent CH3CN/hexanes 
extraction afforded product 6e (23.0 mg, 77% yield) as a 
pale yellow oil. IR (Diamond-ATR) ν 2922, 1685, 1607, 
1508, 1245, 1176, 1033, 963, 778, 683, 548 cm-1; 1H NMR 
(acetone-d6) δ 8.01 (d, J = 8.2 Hz, 2H), 7.44 (d, J = 8.2 Hz, 
2H), 7.22−7.37 (m, 5H), 6.89−7.01 (m, 4H), 6.49 (d, J = 
16.0 Hz, 1H), 5.01 (d, J = 8.2 Hz, 1H), 3.77 (s, 3H); 13C 
{1H} NMR (acetone-d6) δ 164.1 (d, J = 243.1 Hz), 159.5, 
150.4, 141.0 (d, J = 7.7 Hz), 136.0, 134.9, 131.3, 131.2, 
131.1 (d, J = 3.1 Hz), 130.8, 130.4, 129.4, 123.52, 123.50, 
114.8 (d, J = 20.7 Hz), 113.4 (d, J = 22.2 Hz), 55.6, 54.2; 
19F NMR (acetone-d6) δ -115.09 (q, J = 9.3 Hz, 1F); HRMS 









The title compound was derived from (2-methoxyphenyl)(p-
tolyl)methanol (3i) (65.8 mg, 0.288 mmol, 1.0 equiv), 
potassium trifluoro(phenylethynyl)borate (1a) (60.0 mg, 
0.288 mmol, 1.0 equiv), and HBF4·OEt2 (74.6 mg, 0.461 
mmol, 1.6 equiv) in 1.0 mL of CH3CN. Purification by 
automated flash column chromatography on silica gel using 
hexanes/diethyl ether (99:1) afforded product 7 (60.1 mg, 
67% yield) as a yellow oil. IR (Diamond-ATR) ν 1597, 




 1; 1H NMR (CDCl3) δ 7.60−7.62 (m, 1H), 7.44−7.47 (m, 
2H), 7.35 (d, J = 8.2 Hz, 2H), 7.25−7.29 (m, 3H), 7.19−7.23 
(m, 1H), 7.09 (d, J = 7.8 Hz, 2H), 6.95 (t of d, J = 1.1, 7.4 
Hz, 1H), 6.84−6.86 (m, 1H), 5.65 (s, 1H), 3.82 (s, 3H), 2.29 
(s, 3H); 13C {1H} NMR (CDCl3) δ 156.1, 138.8, 136.0, 
131.7, 130.5, 129.0, 128.9, 128.13, 128.05, 127.71, 127.68, 
123.8, 120.9, 110.7, 91.2, 83.3, 55.5, 36.2, 21.0; HRMS 











The title compound was derived from 1-methoxy-2-(3-
phenyl-1-(p-tolyl)prop-2-yn-1-yl)benzene (7) (60.1 mg, 
0.192 mmol, 1.0 equiv) and boron tribromide solution [1.0 
M in methylene chloride] (0.145 g, 0.577 mmol, 3.0 equiv) 
in 2.0 mL of anhydrous DCM. Purification by automated 
flash column chromatography on silica gel using 
hexanes/EtOAc (gradient: 24:1 → 9:1) and subsequent 
CH3CN/hexanes extraction afforded product 8 (42.0 mg, 
73% yield) as a yellow oil. IR (Diamond-ATR) ν 3527, 
1595, 1488, 1454, 1185, 1087, 822, 749, 689 cm-1; 1H NMR 
(CDCl3) δ 7.48−7.52 (m, 2H), 7.41−7.44 (m, 1H), 7.39 (d, J 
= 8.2 Hz, 2H), 7.31−7.35 (m, 3H), 7.19−7.22 (m, 1H), 7.17 
(m, 2H), 6.96 (t of d, J = 1.2, 7.4 Hz, 1H), 6.85 (d of d, J = 
1.2, 8.2 Hz, 1H), 5.50 (s, 1H), 5.44 (s, 1H), 2.35 (s, 3H); 13C 
{1H} NMR (CDCl3) δ 153.3, 137.2, 136.7, 131.7, 129.5, 
129.4, 128.5, 128.23, 128.19, 127.6, 127.5, 123.0, 121.0, 
116.6, 89.1, 85.3, 38.2, 21.0; HRMS (DART-TOF+) m/z 























The title compound was derived from 2-(3-phenyl-1-(p-
tolyl)prop-2-yn-1-yl)phenol (8) (42.0 mg, 0.141 mmol, 1.0 
equiv) and t-BuOK (31.6 mg, 0.282 mmol, 2.0 equiv) in 1.13 
mL of anhydrous dioxane. Purification by automated flash 
column chromatography on silica gel using hexanes/diethyl 
ether (gradient: 99:1 → 49:1) and subsequent 
CH3CN/hexanes extraction afforded product 9 (19.7 mg, 
47% yield) as a yellow solid. Mp 65−68 °C; IR (Diamond-
ATR) ν 1512, 1492, 1453, 1159, 977, 820, 740, 719, 694, 
492, 454 cm-1; 1H NMR (CDCl3) δ 7.57−7.59 (m, 1H), 
7.40−7.45 (m, 3H), 7.20−7.31 (m, 9H), 4.20 (s, 2H), 2.42 (s, 
3H); 13C {1H} NMR (CDCl3) δ 154.3, 152.3, 138.0, 137.0, 
129.5, 129.4, 128.9, 128.8, 128.6, 128.5, 126.5, 123.9, 
122.6, 119.8, 118.1, 111.1, 32.9, 21.3; HRMS (DART-






























The title compound was derived from  
2-methoxytetrahydropyran (18.7 mg, 0.161 mmol, 1.0 
equiv.), potassium trifluoro(phenylethynyl)borate (1a) (50.3 
mg, 0.242 mmol, 1.5 equiv.) and HBF4∙OEt2 (32.9 μL, 0.242 
mmol, 1.5 equiv.) in 1.61 mL of CH3CN (C = 0.1 M). 
Purification by automated flash column chromatography on 
silica gel using hexanes/ethyl acetate (49:1) and subsequent 
CH3CN/hexanes extraction afforded product 10a (24.6 mg, 
82% yield) as a yellow oil. 1H NMR (CDCl3) δ 7.44-7.46 (m, 
2H), 7.28-7.31 (m, 3H), 4.49-4.52 (m, 1H), 4.02-4.07 (m, 
1H), 3.56-3.62 (m, 1H), 1.89-1.94 (m, 2H), 1.75-1.82 (m, 
1H), 1.55-1.65 (m, 3H) ; 13C {1H} NMR (CDCl3) δ 131.7, 













The title compound was derived from  
2-methoxytetrahydropyran (11.6 mg, 0.100 mmol, 1.0 
equiv.), potassium trifluoro(E)-2-phenylethenylborate (31.5 
mg, 0.150 mmol, 1.5 equiv.) and HBF4∙OEt2 (20.4 μL, 0.150 
mmol, 1.5 equiv.) in 1.0 mL of CH3CN (C = 0.1 M). 
Purification by automated flash column chromatography on 
silica gel using hexanes/ethyl acetate (gradient: 99:1 → 
49:1) and subsequent CH3CN/hexanes extraction afforded 
product 10b (6.7 mg, 36% yield) as a yellow oil. 1H NMR 
(CDCl3) δ 7.37-7.39 (m, 2H), 7.19-7.32 (m, 3H), 6.57-6.61 
(m, 1H), 6.18-6.24 (m, 1H), 4.06-4.09 (m, 1H), 3.95-4.00 
(m, 1H), 3.51-3.58 (m, 1H), 1.88-1.91 (m, 1H), 1.72-1.76 
(m, 1H), 1.43-1.65 (m, 4H); 13C {1H} NMR (CDCl3) δ 137.0, 







The title compound was derived from  
2-methoxytetrahydropyran (31.4 mg, 0.271 mmol, 1.0 
equiv.), potassium trifluoro(hex-1-yn-1-yl)borate (1d) (76.3 
mg, 0.406 mmol, 1.5 equiv.) and HBF4∙OEt2 (55.2 μL, 0.406 
mmol, 1.5 equiv.) in 2.71 mL of CH3CN (C = 0.1 M). 
Aqueous work-up afforded product 10c (37.8 mg, 84% yield) 




3.99 (m, 1H), 3.47-3.52 (m, 1H), 2.20-2.24 (m, 2H), 1.80-
1.85 (m, 2H), 1.38-1.57 (m, 8H), 0.90 (t, J = 7.0 Hz, 3H); 13C 
{1H} NMR (CDCl3) δ 85.7, 79.1, 67.3, 66.6, 32.5, 30.7, 25.7, 










The title compound was derived from  
2-methoxytetrahydropyran (17.1 mg, 0.147 mmol, 1.0 
equiv.), potassium trifluoro((3-fluorophenyl)ethynyl)borate 
(1g) (49.8 mg, 0.220 mmol, 1.5 equiv.) and HBF4∙OEt2 (30.0 
μL, 0.220 mmol, 1.5 equiv.) in 1.5 mL of CH3CN (C = 0.1 
M). Purification by automated flash column chromatography 
on silica gel using hexanes/ethyl acetate (49:1) and 
subsequent CH3CN/hexanes extraction afforded product 10d 
(14.3 mg, 48% yield) as a yellow oil. 1H NMR (CDCl3) δ 
7.21-7.29 (m, 2H), 7.12-7.16 (m, 1H), 6.99-7.04 (m, 1H), 
4.48-4.51 (m, 1H), 4.01-4.06 (m, 1H), 3.56-3.62 (m, 1H), 
1.87-1.96 (m, 2H), 1.73-1.82 (m, 1H), 1.55-1.66 (m, 3H); 13C 
{1H} NMR (CDCl3) δ 162.3 (d, J = 246.1 Hz), 129.8 (d, J = 
9.2 Hz), 127.6 (d, J = 3.1 Hz), 124.6 (d, J = 9.2 Hz), 118.5 
(d, J = 23.0 Hz), 115.6 (d, J = 21.5 Hz), 89.1, 83.9, 67.3, 66.7, 












The title compound was derived from  
2-methoxytetrahydropyran (16.1 mg, 0.139 mmol, 1.0 
equiv.), potassium trifluoro((4-methoxyphenyl)ethynyl)-
borate (1b) (49.5 mg, 0.208 mmol, 1.5 equiv.) and 
HBF4∙OEt2 (28.3 μL, 0.208 mmol, 1.5 equiv.) in 1.39 mL 
of CH3CN (C = 0.1 M). Purification by automated flash 
column chromatography on silica gel using hexanes/ethyl 
acetate (gradient: 99:1 → 97:3) and subsequent 
CH3CN/hexanes extraction afforded product 10e (10.2 mg, 
34% yield) as a yellow oil. 1H NMR (CDCl3) δ 7.37-7.40 
(m, 2H), 6.81-6.83 (m, 2H), 4.47-4.49 (m, 1H), 4.02-4.07 
(m, 1H), 3.80 (s, 3H), 3.55-3.60 (m, 1H), 1.90 (m, 2H), 
1.74-1.81 (m, 1H), 1.55-1.63 (m, 3H); 13C {1H} NMR 
(CDCl3) δ 133.2, 114.9, 113.8, 86.7, 85.0, 67.6, 66.7, 55.2, 
















The title compound was derived from  
2-ethoxytetrahydrofuran (20.2 mg, 0.174 mmol, 1.0 equiv.), 
potassium trifluoro(phenylethynyl)borate (1a) (54.4 mg, 
0.261 mmol, 1.5 equiv.) and HBF4∙OEt2 (35.6 μL, 0.261 
mmol, 1.5 equiv.) in 1.74 mL of CH3CN (C = 0.1 M). 
Purification by automated flash column chromatography on 
silica gel using hexanes/ethyl acetate (gradient: 50:1  17:1) 
and subsequent CH3CN/hexanes extraction afforded product 
11a (27.5 mg, 92% yield) as a yellow oil. 1H NMR (CDCl3) 
δ 7.42-7.44 (m, 2H), 7.28-7.30 (m, 3H), 4.79-4.83 (m, 1H), 
3.98-4.04 (m, 1H), 3.83-3.88 (m, 1H), 2.20-2.26 (m, 1H), 
2.04-2.12 (m, 2H), 1.90-1.98 (m, 1H); 13C {1H} NMR 
(CDCl3) δ 131.7, 128.19, 128.16, 122.78, 89.0, 84.4, 68.6, 
67.9, 33.4, 25.5; IR (Diamond-ATR) v 2979, 2950, 2870, 









The title compound was derived from  
2-ethoxytetrahydrofuran (15.7 mg, 0.135 mmol, 1.0 equiv.), 
potassium trifluoro(naphthalene-1-ylethynyl)borate (1j) 
(52.2 mg, 0.202 mmol, 1.5 equiv.) and HBF4∙OEt2 (27.5 μL, 
0.202 mmol, 1.5 equiv.) in 1.35 mL of CH3CN (C = 0.1 M). 
Purification by automated flash column chromatography on 
silica gel using hexanes/ethyl acetate (99:1) and subsequent 
CH3CN/hexanes extraction afforded product 11b (29.7 mg, 
99% yield) as a yellow oil. 1H NMR (CDCl3) δ 8.30 (d, J = 
8.2 Hz, 1H), 7.81 (t, J = 9.0 Hz, 2H), 7.66 (d, J = 7.0 Hz, 
1H), 7.48-7.57 (m, 2H), 7.40 (t, J, = 7.4 Hz, 1H), 4.95-4.98 
(m, 1H), 4.05-4.11 (m, 1H), 3.89-3.94 (m, 1H), 2.25-2.35 
(m, 1H), 2.11-2.23 (m, 2H), 1.93-2.04 (m, 1H); 13C {1H} 
NMR (CDCl3) δ 133.3, 133.1, 130.5, 128.7, 128.2, 126.7, 
126.3, 126.1, 125.1, 120.4, 94.1, 82.5, 68.8, 67.9, 33.6, 25.5; 
IR (Diamond-ATR) v 2978, 2948, 2868, 1394, 1331, 1045, 





The title compound was derived from  
2-ethoxytetrahydrofuran (15.3 mg, 0.131 mmol, 1.0 equiv.), 
potassium ((4-butylphenyl)ethynyl)trifluoroborate (1c) 
(52.1 mg, 0.197 mmol, 1.5 equiv.) and HBF4∙OEt2 (26.8 μL, 




Purification by automated flash column chromatography on 
silica gel using hexanes/ethyl acetate (gradient: 99:1  
16:1) afforded product 11c (28.0 mg, 93% yield) as a yellow 
oil. 1H NMR (CDCl3) δ 7.32-7.35 (m, 2H), 7.09-7.11 (m, 
2H), 4.79-4.82 (m, 1H), 3.98-4.03 (m, 1H), 3.82-3.87 (m, 
1H), 2.58 (t, J = 7.8 Hz, 2H), 2.18-2.27 (m, 1H), 2.02-2.14 
(m, 2H), 1.88-1.98 (m, 1H), 1.53-1.61 (m, 2H), 1.28-1.38 
(m, 2H), 0.91 (t, J = 7.4 Hz, 3H); 13C {1H} NMR (CDCl3) δ 
143.3, 131.6, 128.3, 119.9, 88.3, 84.6, 68.6, 67.8, 35.5, 33.4, 
33.3, 25.5, 22.3, 13.9; IR (Diamond-ATR) v 2955, 2928, 









The title compound was derived from  
2-ethoxytetrahydrofuran (14.5 mg, 0.124 mmol, 1.0 equiv.), 
potassium trifluoro((3,4-dichlorophenyl)ethynyl)borate 
(1e) (51.7 mg, 0.187 mmol, 1.5 equiv.) and HBF4∙OEt2 (25.4 
μL, 0.187 mmol, 1.5 equiv.) in 1.24 mL of CH3CN (C = 0.1 
M). Purification by automated flash column 
chromatography on silica gel using hexanes/ethyl acetate 
(99:1) and subsequent CH3CN/hexanes extraction afforded 
product 11e (19.3 mg, 64% yield) as a yellow oil. 1H NMR 
(CDCl3) δ 7.51-7.52 (m, 1H), 7.35-7.37 (m, 1H), 7.23-7.26 
(m, 1H), 4.77-4.80 (m, 1H), 3.96-4.02 (m, 1H), 3.83-3.88 
(m, 1H), 2.19-2.28 (m, 1H), 2.02-2.14 (m, 2H), 1.90-1.99 
(m, 1H); 13C {1H} NMR (CDCl3) δ 133.3, 132.7, 132.4, 









The title compound was derived from  
2-ethoxytetrahydrofuran (17.2 mg, 0.148 mmol, 1.0 
equiv.), potassium trifluoro((4-methoxyphenyl)ethynyl)-
borate (1b) (53.0 mg, 0.223 mmol, 1.5 equiv.) and 
HBF4∙OEt2 (30.3  μL, 0.223 mmol, 1.5 equiv.) in 1.48 mL 
of CH3CN (C = 0.1 M). Purification by automated flash 
column chromatography on silica gel using hexanes/ethyl 
acetate (gradient: 99:1  12:1) afforded product 11d (23.3 
mg, 78% yield) as a yellow oil. 1H NMR (CDCl3) δ 7.35-
7.38 (m, 2H), 6.80-6.83 (m, 2H), 4.78-4.81 (m, 1H), 3.98-
4.03 (m, 1H), 3.82-3.87 (m, 1H), 3.79 (s, 3H), 2.18-2.25 
(m, 1H), 2.02-2.14 (m, 2H), 1.89-1.98 (m, 1H); 13C {1H} 
NMR (CDCl3) δ 159.5, 133.1, 114.9, 113.8, 87.6, 84.3, 
68.7, 67.8, 55.2, 33.4, 25.5; IR (Diamond-ATR) v 2952, 





(Diamond-ATR) v 2979, 2951, 2870, 1462, 1130, 1048, 









The title compound was derived from  
2-ethoxytetrahydrofuran (18.3 mg, 0.158 mmol, 1.0 equiv.), 
potassium trifluoro((3-fluorophenyl)ethynyl)borate (1g) 
(53.5 mg, 0.237 mmol, 1.5 equiv.) and HBF4∙OEt2 (32.2 μL, 
0.237 mmol, 1.5 equiv.) in 1.58 mL of CH3CN (C = 0.1 M). 
Purification by automated flash column chromatography on 
silica gel using hexanes/ethyl acetate (50:1) and subsequent 
CH3CN/hexanes extraction afforded product 11f (18.4 mg, 
61% yield) as a yellow oil. 1H NMR (CDCl3) δ 7.19-7.28 (m, 
2H), 7.11-7.14 (m, 1H), 6.98-7.03 (m, 1H), 4.79-4.82 (m, 
1H), 3.98-4.03 (m, 1H), 3.84-3.89 (m, 1H), 2.20-2.29 (m, 
1H), 2.03-2.13 (m, 2H), 1.90-1.99 (m, 1H); 13C {1H} NMR 
(CDCl3) δ 162.3 (d, J = 246.1 Hz), 129.8 (d, J = 9.2 Hz), 
127.5 (d, J = 3.8 Hz), 124.6 (d, J = 9.2 Hz), 118.5 (d, J = 22.2 
Hz), 115.6 (d, J = 21.5 Hz), 90.1, 83.2 (d, J = 3.8 Hz), 68.5, 
68.0, 33.3, 25.5; 19F NMR (CDCl3) δ -113.14 (q, J = 5.9 Hz, 
1F); IR (Diamond-ATR) v 2980, 2952, 2872, 1579, 1485, 












The title compound was derived from  
2-ethoxytetrahydrofuran (14.5 mg, 0.123 mmol, 1.0 equiv.), 
potassium trifluoro((2-(trifluoromethyl)phenyl)ethynyl)-
borate (1h) (51.7 mg, 0.187 mmol, 1.5 equiv.) and HBF4∙OEt2 
(25.5 μL, 0.187 mmol, 1.5 equiv.) in 1.25 mL of CH3CN (C = 
0.1 M). Purification by automated flash column 
chromatography on silica gel using hexanes/ethyl acetate 
(gradient: 99:1  16:1) and subsequent CH3CN/hexanes 
extraction afforded product 11g (24.7 mg, 82% yield) as a 
yellow oil. 1H NMR (CDCl3) δ 7.62-7.64 (m, 1H), 7.56-7.58 
(m, 1H), 7.45-7.48 (m, 1H), 7.37-7.40 (m, 1H), 4.85-4.87 (m, 
1H), 3.98-4.04 (m, 1H), 3.85-3.91 (m, 1H), 2.18-2.26 (m, 1H), 
2.06-2.17 (m, 2H), 1.90-1.99 (m, 1H); 13C {1H} NMR 
(CDCl3) δ = 133.9, 131.8, 131.3, 128.0, 125.7 (q, J = 5.4 Hz), 
123.5 (q, J = 273.8 Hz), 121.1 (q, J = 2.3 Hz), 95.0, 80.3, 68.5, 
67.9, 33.1, 25.1; 19F NMR (CDCl3) δ -62.48 (s, 3F); IR 
(Diamond-ATR) v 2981, 2874, 1315, 1166, 1128, 1109, 1049, 













The title compound was derived from  
2-ethoxytetrahydrofuran (22.9 mg, 0.197 mmol, 1.0 equiv.), 
potassium trifluoro(hex-1-yn-1-yl)borate (1d) (55.6 mg, 
0.296 mmol, 1.5 equiv.) and HBF4∙OEt2 (40.2 μL, 0.296 
mmol, 1.5 equiv.) in 1.97 mL of CH3CN (C = 0.1 M). 
Aqueous workup afforded product 11h (19.3 mg, 64% yield) 
as a yellow oil. A pure sample was obtained after the work-
up. Attempts to run the crude product through a pad of silica 
gel resulted in the decomposition of 11h. 1H NMR (CDCl3) 
δ 4.53-4.57 (m, 1H), 3.91-3.97 (m, 1H), 3.75-3.80 (m, 1H), 
2.20 (td, J = 2.0, 7.0 Hz, 2H), 2.08-2.16 (m, 1H), 1.97-2.07 
(m, 1H), 1.82-1.95 (m, 2H), 1.44-1.52 (m, 2H), 1.35-1.42 (m, 
2H), 0.90 (t, J = 7.4 Hz, 3H); 13C {1H} NMR (CDCl3) δ 85.2, 
79.9, 68.4, 67.6, 33.5, 30.7, 25.4, 21.9, 18.4, 13.6; IR 
(Diamond-ATR) v 2956, 2931, 2871, 1458, 1355, 1332, 










The title compound was derived from  
2-ethoxytetrahydrofuran (20.0 mg, 0.172 mmol, 1.0 equiv.), 
potassium trans-styryltrifluoroborate (54.2 mg, 0.258 mmol, 
1.5 equiv.) and HBF4∙OEt2 (35.1 μL, 0.258 mmol, 1.5 equiv.) 
in 1.72 mL of CH3CN (C = 0.1 M). Purification by automated 
flash column chromatography on silica gel using 
hexanes/ethyl acetate (gradient: 99:1  19:1) and 
subsequent CH3CN/hexanes extraction afforded product 12a 
(22.3 mg, 74% yield) as a yellow oil. 1H NMR (CDCl3) δ 
7.37-7.39 (m, 2H), 7.28-7.32 (m, 2H), 7.20-7.25 (m, 1H), 
6.58 (d, J = 16.0 Hz, 1H), 6.20 (dd, J = 6.3, 15.6 Hz, 1H), 
4.44-4.50 (m, 1H), 3.94-4.00 (m, 1H), 3.81-3.86 (m, 1H), 
2.08-2.16 (m, 1H), 1.88-2.04 (m, 2H), 1.67-1.75 (m, 1H); 13C 
{1H} NMR (CDCl3) δ 136.8, 130.5, 130.4, 128.5, 127.4, 
126.4, 79.6, 68.1, 32.4, 25.9; IR (Diamond-ATR) v 2971, 






The title compound was derived from  
2-ethoxytetrahydrofuran (18.1 mg, 0.156 mmol, 1.0 equiv.), 
potassium 2-(3-fluorophenyl)vinyltrifluoroborate (53.4 mg, 
0.234 mmol, 1.5 equiv.) and HBF4∙OEt2 (31.9 μL, 0.234 
mmol, 1.5 equiv.) in 1.56 mL of CH3CN (C = 0.1 M). 
Purification by automated flash column chromatography on 
silica gel using hexanes/ethyl acetate (gradient: 99:1  19:1) 




12b (23.4 mg, 78% yield) as a yellow oil. 1H NMR (CDCl3) 
δ 7.23-7.28 (m, 1H), 7.06-7.14 (m, 2H), 6.89-6.94 (m, 1H), 
6.55 (d, J = 15.6 Hz, 1H), 6.22 (dd, J = 6.3, 16.0 Hz, 1H), 
4.45-4.50 (m, 1H), 3.94-4.00 (m, 1H), 3.82-3.87 (m, 1H), 
2.09-2.17 (m, 1H), 1.89-2.04 (m, 2H), 1.65-1.75 (m, 1H); 
13C {1H} NMR (CDCl3) δ 163.0 (d, J = 245.4 Hz), 139.2 (d, 
J = 7.7 Hz), 132.0, 129.9 (d, J = 8.4 Hz), 129.1 (d, J = 3.1 
Hz), 122.3 (d, J = 3.1 Hz), 114.2 (d, J = 21.5 Hz), 112.8 (d, 
J = 21.5 Hz), 79.3, 68.2, 32.3, 25.9; 19F NMR (CDCl3) δ  
-113.71 (q, J = 6.3 Hz, 1F); IR (Diamond-ATR) v 2972, 










The title compound was derived from 2-
ethoxytetrahydrofuran (14.4 mg, 0.124 mmol, 1.0 equiv.), 
potassium (E)-trifluoro(4-(trifluoromethyl)-styryl)borate 
(51.7 mg, 0.186 mmol, 1.5 equiv.) and HBF4∙OEt2 (25.3 μL, 
0.186 mmol, 1.5 equiv.) in 1.24 mL of CH3CN (C = 0.1 M). 
Purification by automated flash column chromatography on 
silica gel using hexanes/ethyl acetate (gradient: 99:1 → 16:1) 
and subsequent CH3CN/hexanes extraction afforded product 
12c (23.5 mg, 78% yield) as a yellow oil. 1H-NMR (CDCl3) 
δ 7.55 (d, J = 8.2 Hz, 2H), 7.45 (d, J = 8.2 Hz, 2H), 6.62 (d, 
J = 16.0 Hz, 1H), 6.31 (dd, J = 6.6, 16.0 Hz, 1H), 4.50 (q, J 
= 6.6 Hz, 1H), 3.96–4.01 (m, 1H), 3.83–3.89 (m, 1H), 2.11–
2.19 (m, 1H), 1.92–2.04 (m, 2H), 1.68–1.77 (m, 1H); 13C 
{1H} NMR (CDCl3) δ 140.3 (q, J = 1.5 Hz), 133.3, 129.4, 
129.1, 128.8, 126.5, 125.4 (q, J = 3.8 Hz), 79.2, 68.3, 32.3, 
25.9; 19F NMR (CDCl3) δ −62.50 (s, 1F); IR (Diamond-ATR) 










The title compound was derived from  
2-ethoxytetrahydrofuran (18.5 mg, 0.159 mmol, 1.0 equiv.), 
potassium (E)-trifluoro(4-methylstyryl)borate (2) (53.6 mg, 
0.239 mmol, 1.5 equiv.) and HBF4∙OEt2 (32.5 μL, 0.239 
mmol, 1.5 equiv.) in 1.59 mL of CH3CN (C = 0.1 M). 
Purification by automated flash column chromatography on 
silica gel using hexanes/ethyl acetate (gradient: 99:1  16:1) 
afforded product 12d (16.1 mg, 54% yield) as a yellow oil. 
1H NMR (CDCl3) δ 7.26-7.28 (m, 2H), 7.10-7.11 (m, 2H), 




4.45 (q, J = 6.7 Hz, 1H), 3.94-3.99 (m, 1H), 3.80-3.86 (m, 
1H), 2.32 (s, 3H), 2.07-2.15 (m, 1H), 1.88-2.01 (m, 2H), 
1.66-1.75 (m, 1H); 13C {1H} NMR (CDCl3) δ 137.3, 134.1, 
130.4, 129.4, 129.2, 126.3, 79.77, 68.1, 32.4, 25.9, 21.2; IR 














The title compound was derived from 2-
ethoxytetrahydrofuran (13.9 mg, 0.120 mmol, 1.0 equiv.), 
potassium (E)-(2-([1,1′-biphenyl]-4-yl)vinyl)trifluoro-
borate (51.4 mg, 0.180 mmol, 1.5 equiv.), and HBF4∙OEt2 
(24.5 μL, 0.180 mmol, 1.5 equiv.) in 1.20 mL of CH3CN (C 
= 0.1 M). Purification by automated flash column 
chromatography on silica gel using hexanes/ethyl acetate 
(gradient: 99:1 → 13:1) and subsequent CH3CN/hexanes 
extraction afforded product 12e (21.6 mg, 72% yield) as a 
white solid. 1H-NMR (CDCl3) δ 7.53–7.60 (m, 4H), 7.40–7.46 
(m, 4H), 7.31–7.35 (m, 1H), 6.62 (d, J = 15.6 Hz, 1H), 6.25 
(dd, J = 6.6, 15.6 Hz, 1H), 4.49 (q, J = 6.6 Hz, 1H), 3.95–4.01 
(m, 1H), 3.82–3.86 (m, 1H), 2.10–2.18 (m, 1H), 1.89–2.02 (m, 
2H), 1.68–1.77 (m, 1H); 13C {1H} NMR (CDCl3) δ 140.7, 
140.2, 135.9, 130.6, 129.9, 128.7, 127.2, 127.1, 126.9, 126.8, 
79.7, 68.2, 32.4, 25.9; IR (Diamond-ATR) v 2928, 2852, 1486, 
1048, 971, 854, 758, 687, 489 cm−1; HRMS (DART-TOF+) 









The title compound was derived from 2-
ethoxytetrahydrofuran (18.7 mg, 0.161 mmol, 1.0 equiv.), 
potassium trifluoro(1H-inden-2-yl)borate (53.6 mg, 0.242 
mmol, 1.5 equiv.) and HBF4∙OEt2 (32.9 μL, 0.242 mmol, 1.5 
equiv.) in 1.61 mL of CH3CN (C = 0.1 M). Purification by 
automated flash column chromatography on silica gel using 
hexanes/ethyl acetate (gradient: 99:1 → 13:1) and 
subsequent CH3CN/hexanes extraction afforded product 12f 
(23.6 mg, 79% yield) as a yellow oil. 1H-NMR (CDCl3) δ 
7.40–7.42 (m, 1H), 7.30–7.32 (m, 1H), 7.21–7.25 (m, 1H), 
7.11–7.15 (m, 1H), 6.71 (s, 1H), 4.82 (t, J = 7.0 Hz, 1H), 3.97–
4.02 (m, 1H), 3.84–3.90 (m, 1H), 3.39 (s, 2H), 2.15–2.23 (m, 
1H), 1.95–2.03 (m, 2H), 1.81–1.89 (m, 1H); 13C {1H} NMR 
(CDCl3) δ 150.4, 144.7, 143.2, 126.6, 126.3, 124.2, 123.6, 
120.6, 77.7, 68.2, 38.1, 32.1, 26.0; IR (Diamond-ATR) v 2971, 




APPENDIX II: NMR SPECTRA 






































































































































































































































































































































































































































































































































































































































APPENDIX III: NMR STUDIES 
 
NMR 1:  


























NMR 2:  





























14.7 mg of potassium phenylacetylenetrifluoroborate 1a in 0.6 mL of CD3CN was transferred to a NMR tube and the following 


























NMR 4:  
In a NMR tube containing 14.7 mg of potassium phenylacetylenetrifluoroborate 1a (1.0 equiv.) and 0.6 mL of CD3CN, 16 μL of 


























NMR 5:  
In a NMR tube containing 14.0 mg of 4-methylbenzhydryl alcohol (1.0 equiv.) and 0.6 mL of CD3CN, 16 μL of HBF4·OEt2 (1.6 
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